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Bovine viral diarrhoea (BVD) is a well-established disease in New Zealand beef and dairy 
cattle that causes significant economic losses for the industries each year.  The pathogenesis of 
the disease is well understood and there is a wide range of reliable diagnostic tools that have 
allowed many European countries to successfully eradicate BVD through coordinated national 
disease control programmes.  However, it is difficult to directly apply many of these 
frameworks in New Zealand due to the unique characteries of the pastoral farming systems that 
create different logistical and epidemiological challenges. There is a strong need to identify the 
most cost-effective means of applying existing diagnostic tests to design a feasible national 
control programme for New Zealand.  To support this goal, this thesis has focused on filling 
two existing knowledge gaps: one around the performance of BVD diagnostics tests in herd 
and industry level disease control programmes and the other around using molecular diagnostic 
test methods to characterise the circulating bovine viral diarrhoea virus (BVDV) strains in the 
cattle populations.   
The last formal literature review on BVD diagnostic tests was published more than 15 years 
ago and there have been significant advances in the availability and performance of the tests 
since then.  In Chapter 2, a non-systematic review was conducted on the evolution of BVD 
diagnostic tests over the past 60 years and how they have been applied to different herd and 
industry level BVD control programmes. The review includes an in-depth overview of key 
feature in the pathogenesis of BVD that impact test performance followed by detailed 
descriptions of the different diagnostic methodologies, their performance and their current 
applications. The discussion section highlights the remaining limitations and technical gaps in 
the current BVD diagnostic tests along with suggestions for future research directions.  
In particular, molecular epidemiology has been successfully applied in some countries as a part 
of their BVD control to understand suspected transmission routes but has not yet been applied 
in New Zealand.  As a preliminary investigation, Chapter 3 was designed to understand current 
circulating BVDV strains in dairy cattle across New Zealand using a convenience sample virus-
positive serum samples that were submitted to commercial diagnostic laboratories during the 
study time period.  Both the 5’UTR and NPro genes were sequenced from each sample to 
identify the strain type and phylogenetic analyses were performed to explore the genetic 
relatedness of each sequence.  Although BVDV 1-A was found as the only subtype circulating 
among dairy cattle, there was a high variation among the sequences within group 1-A. The 
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phylogenetic analysis showed a fair homogeny of New Zealand dairy isolates with overseas 
isolates, particularly with BVDV strains previously identified in China. There was also 100% 
homogeny between the New Zealand dairy isolates and those from cattle that were recently 
sequenced for another study, which is most likely from the sales of dairy calves into the beef 
industry for fattening.  Several farms were also found to have multiple different 
phylogenetically distinct BVDV strains, which suggests that they may have been infected from 
multiple different sources.  Molecular sequencing may provide a valuable tool for helping 
farmers understand the origins of BVDV outbreaks. However, there were some limitations with 
the sampling and detection methods used.  Future research directions were proposed in the 
discussion including broadening the study into a national survey with adequate representative 
samples.    
Finally, Chapter 4 provides a brief discussion of how the findings from this work can be used 
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 Overview of bovine viral diarrhoea 
Bovine viral diarrhoea (BVD) is a highly contagious disease of cattle that can also affect sheep, 
goats, deer, camelids, and swine (Abu Elzein & AlKhalyifa, 2012). The disease causes severe 
economic loses to the dairy and beef industries worldwide and is listed as notifiable by the OIE 
(World Organization for Animal Health) under cattle diseases and infections (OIE, 2021).  
Depending on the pathogenic properties of the virus, the virulence of the virus is highly variable 
with possible outcomes including respiratory, enteric or lethal hemorrhagic conditions 
accompanied by transient immunosuppression (Baker, 1995). However, the most significant 
economic impacts occur when pregnant animals get infected and the virus crosses the placenta 
to attack the fetus. Depending on the time of infection, the outcome could be early embryonic 
death, abortions, birth defects, stillbirths, or the birth of persistently infected (PI) calves 
(Volker, Hans, & Ann, 2005). Persistently infected animals are immunotolerant to the virus 
and have been identified as the main source of  transmission because they continuously shed 
large amounts of virus to the environment throughout their lifespan (Houe, 1999a). Therefore, 
the fundamental principle of any BVD control or eradication program is to reduce the 
prevalence of existing PI animals and prevent the creation of new PI animals.  
 Genetic diversity of bovine viral diarrhoea virus  
Bovine viral diarrhoea virus (BVDV) is a member of family Flaviviridae. This family 
comprises a large group of small (40-50nm) enveloped single–stranded, non-segmented 
positive sense RNA viruses (Neufeldt, Cortese, Acosta, & Bartenschlager, 2018). The 9-13kb 
genome of the family Flaviviridae contains a single, long ORF flanked by 5’- and 3’-terminal 
non-coding regions, that forms specific secondary structures required for genome replication 
and translation (Simmonds, Becher, Bukh, Gould, Meyers, Monath, Muerhoff, Pletnev, Rico-
Hesse, Smith, & Stapleton, 2017). These regions encode for approximately 12 structural and 
non-structural proteins including Npro, C, Erns,E1, E2, P7, NS2/3, NS4A, NS4B, and NS5A 
(Richard E. Booth, Thomas, El-Attar, Gunn, & Brownlie, 2013a). 
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There are four genera of family Flaviviridae: Flavivirus, Hepacivirus, Pegivirus and Pestivirus 
and BVDV belongs to genus Pestivirus. The genus pestivirus comprises many species 
including viral species such as Bovine Viral Diarrhoea viruses, Border disease virus (BDV), 
and Classical swine fever virus (CSFV) which are known to be economically more important 
viruses among the others in the genus. Bovine viral diarrhoea is caused by one on three 
Pestivirus species: bovine viral diarrhoea virus 1 (BVDV‐1/Pestivirus A), bovine viral 
diarrhoea virus 2 (BVDV‐2/ Pestivirus B) and HoBi‐like virus (BVDV‐3/Pestivirus H/ bovine 
atypical pestivirus) (Evans et al., 2019). 
In cell culture, all pestiviruses show two different biotypes, named cytopathic (cp) and non-
cytopathic (non-cp) (Lanyon, Hill, Reichel, & Brownlie, 2014; Tautz, Tews, & Meyers, 2015), 
where the non-cp strains are  commonly found in the field. Non-cytopathic viruses are 
associated with the majority of BVDV infections (>90%) and cause mild to severe transient 
infection (TI) as well as persistent infection. Non-cp BVDV is the only biotype that has been 
observed clinically or experimentally to cause BVDV persistent infection (Sasha R. Lanyon, 
Fraser I. Hill, et al., 2014; Zhang et al., 2014). CP biotypes cause severe acute and per-acute 
transient disease as well as mucosal disease (MD) in superinfected PI animals (Khodakaram-
Tafti & Farjanikish, 2017; Walz et al., 2010).  
Variations among BVDV strains can be evaluated by different methods, including monoclonal 
antibody reactions, cross-neutralization tests and molecular analysis.  The genetic analysis of 
BVDV has further classified the virus into sub genotypes and identified as BVDV-1 has 21 
subtypes (1a-1u), BVDV-2 has three subtypes and BVDV-3 has four subtypes (Yesilbag, 
Alpay, & Becher, 2017). Partial 5’UTR sequences have been most frequently used for 
phylogenetic analyses and genotyping of BVDV isolates, followed by Npro and E2 coding 
sequences. BVDV phylogenies using the 5’UTR alone has shown some limitations for the 
phylogenetic analyses due to restricted sequence length and lack of diversity (Becher et al., 
1997; Xia, Liu, Wahlberg, Baule, & Belák, 2007; Yesilbag et al., 2017). The lack of 
information does not allow to clearly infer relationships within the major clades, and some 
branches of the phylogenetic tree. To overcome the above issues, analysis of longer sequences 
such as complete Npro and E2 coding regions are also recommended along with 5’UTR (Becher 
et al., 1997; Adam Chernick, Godson, & van der Meer, 2014).   
Epidemiological studies have shown that various BVDV subgenotypes predominate in 
different countries   and that has been shown to be invariably dependent on the geographical 
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location. For example, in Australia, Mexico and the UK, BVDV Type 1C sub-genotype is 
prevalent (Richard E. Booth et al., 2013a; Gómez-Romero, Basurto-Alcántara, Verdugo-
Rodríguez, Bauermann, & Ridpath, 2017; Lanyon & Reichel, 2014; Vilcek, Durkovic, 
Kolesarova, & Paton, 2005), in Austria, Type 1F, in Germany, Type 1B and Type 1D, in Italy 
Type 1B and Type 1E, in the USA and Canada, Type 1A and Type 1B, in India Type 1B 
(Vilcek et al., 2005), and in Switzerland, Type 1H is the most predominant sub-genotype 
(Stalder et al., 2018).  
 Global status of BVDV 
BVDV has been detected in 88 countries worldwide (Richter et al., 2019) and it is currently 
endemic in most cattle producing countries. The direct losses due to BVD has been estimated 
between NZ$3.45 to NZ$988.04 per animal (Han J-H, 2018; Richter et al., 2017) with the total 
loss due to the disease predicted to be much higher when considering indirect expenses such 
as diagnostic testing, vaccination, and the costs of implementing other BVD biosecurity 
measures.  Considering these epidemiological and economical features of BVDV infections, 
many countries have implemented compulsory or voluntary programs aimed at controlling or 
eradicating BVD.  Several Western European countries including Norway, Sweden, Finland 
and Denmark have already achieved BVD free status.  Recent analysis revealed evidence that 
the global prevalence of the disease has decreased over time after  increasing numbers of 
countries have successfully implemented control strategies (Scharnböck et al., 2018).  
However, the high BVD prevalence still remains in countries that have failed to implement any 
BVD control programmes so far.  This includes New Zealand where there have been no 
coordinated national efforts to eradicate the virus since it was first identified in the 1960s.  
 Bovine viral diarrhoea in New Zealand 
1.4.1 Prevalence of BVD 
The first BVD case in New Zealand was reported in 1960s  in a herd of cattle (Salisbury et al., 
1961) and additional cases were subsequently found on different farms confirming the active 
circulation of the virus within the country (Fastier & Hansen, 1966).  Since then, the virus has 
become endemic in both dairy and beef sectors causing more than NZ$150 million each year 
in direct production losses with an additional NZ$44.5 spent on disease control (C. Heuer, 
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Healy, & Zerbini, 2007). The latest statistics show  more than 65% of dairy herds are 
conducting annual bulk milk testing through a single diagnostic laboratory (Gates, Han, Evans, 
Weston, & Heuer, 2019). At present, approximately 45 % dairy herds are classified as having 
high or very high antibody levels with approximately 5 to 10% of dairy herds believed to be 
currently actively infected. The prevalence of PCR positive bulk milk samples has dropped 
from 15% to 5% from 2010 to 2017, which suggests that voluntary control measures 
implemented by dairy farmers are having a significant impact in reducing disease prevalence 
in the industry (Gates, Evans, Heuer, Voges, & Weston, 2020).  
Data on the epidemiology and economics of BVD in the New Zealand beef cattle industry is 
much more limited due to the extensive nature of beef production where cattle are often 
minimally handled and there are many challenges of conducting diagnostic tests (Gates, Evans, 
Han, Heuer, & Weston, 2020; Han J-H, 2018). However, previous small scale cross-sectional 
studies have reported around 65% of beef herds had evidence of previous exposure to BVD 
virus and approximately 50% of herds were actively infected (Cuttance & Cuttance, 2014; C 
Heuer, Tattersfield, West, & Olson, 2008). However, these statistics were based on limited 
number of potentially non-representative herds and, to our knowledge, follow-up studies have 
not been done. Many beef farmers do not perform annual screening tests because of the 
perceived costs of BVD control as well as the logistical difficulties in yarding extensively 
grazed beef calves when they are in the appropriate 10–18-month age range to conduct 
sampling. Previous analysis of National Diagnostic Laboratory Testing Data suggest that fewer 
than 5 to 10% of beef herds conduct serological screening with limited uptake of individual 
animal testing in herds with suspected active infections (Gates, Han, et al., 2019). These issues 
make it difficult to track national trends of disease prevalence in New Zealand beef cattle.  
 A  study conducted in New Zealand cattle in 1998 grouped 20 isolates collected from 1967 to 
1997 into the BVDV1 species (Vilček, Björklund, Belák, Horner, & Meers, 1998). Since then, 
there have only been two studies on the BVDV genotypes present in New Zealand.  Both 
identified the presence of only the BVDV1 genotype, but identified the subtypes 1A and 1C (J. 
H. Han, Weir, Weston, Heuer, & Gates, 2018). BVDV-2  has not been detected in New Zealand 
(Ridpath, 2010).  
1.4.2 Control strategies 
Decades from New Zealand’s first case of BVD, the national BVD steering committee was 
established in 2005 with the purpose of educating veterinarians and farmers about BVD to 
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improve the voluntary uptake of control measures (Gates, Evans, Weir, Heuer, & Weston, 
2019).   The committee membership includes veterinary technical experts from academia, 
clinical practice, and industry who review the science around BVD to make recommendations 
for controlling the disease in New Zealand and have been driving force behind many BVD 
research and extension efforts over the past 15 years.  One of the main limitations identified by 
the BVD Steering Committee with controlling BVD in New Zealand was the lack of farmer 
awareness about the presence of disease in their herds. This BVD awareness has been slowly  
changing with the introduction of cost effective testing protocols such as bulk tank milk testing 
in dairy herds introduced in 2010 and the pooled serum antibody test introduced in 2011 which 
provided an equivalent inexpensive means of screening beef cattle herds for evidence of active 
viral transmission.  With the introduction of the National Animal Identification and Tracing 
(NAIT) system in New Zealand in 2013, all the tools were now available to support the 
implementation of a national BVD control programme.  Furthermore, there has been evidence 
that the dairy industry has also made significant voluntary progress in controlling BVD by 
reducing the prevalence on herds with positive bulk milk PCR tests, which suggests the 
potential for industry support of a national disease control programme (Gates, Evans, Heuer, 
et al., 2020). However, there were still uncertainties about which strategy would be the most 
cost-effective for New Zealand. In July 2017, a three-year BVD research project 
(www.bvdfree.org.nz) was launched to fill in the remaining knowledge gaps to evaluate the 
cost-effectiveness of BVD control programmes.  
Limitations and Knowledge gaps of BVD control  
Although many European countries that have successfully implemented programmes for BVD 
control, there are several unique features of the New Zealand pastoral farming systems such as 
its highly seasonal nature and extensive grazing practices resulting in infrequent handling of 
beef and non-dairy cattle that require consideration when determining which strategies are 
likely to be the most cost-effective (Han J-H, 2018). An important aspect of this will be 
developing robust screening programmes at both the herd and national levels based on current 
knowledge about the performance of BVD diagnostic tests as well as knowledge of the 
prevalence and distribution of actively circulating strains (J.-H. Han et al., 2018).   The last 
formal literature review on BVD diagnostic tests was published in 2005 (Sandvik, 2005b) and 
there have since been many advances in the test methodologies that have implications for their 
use in BVD control programmes. Another critical knowledge gap in New Zealand is around 
the circulating BVD strains since the last study on BVDV genotypes of BVDV in New Zealand 
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was published in 1998 (Vilček et al., 1998) and there are likely to have been changes in the 
molecular epidemiology since that time.  
 Summary of objectives 
The main aims of the thesis were to (1) provide an overview of diagnostic testing strategies of 
the world that could serve as a helpful a reference for making decisions about future BVD 
control programmes in New Zealand and (2) address the current deficits in the understanding 
of circulating BVDV subtypes in dairy farms across New Zealand as there have been few 
previous studies in this area.  
With those objectives in mind, Chapter 2 will cover the evolution and application of diagnostic 
testing strategies for BVDV in cattle as a non-systematic review. Molecular epidemiology has 
not been applied in national BVD control programmes in New Zealand so far and the main 
limitation could be recognized as lack of understanding of current circulating BVDV virus 
strains across the country. To address the knowledge gap, a preliminary phylogenetic analysis 
has been done across New Zealand dairy animals and has reported in Chapter 3. This chapter 
will cover an overview of circulating BVDV strains in dairy cattle in New Zealand and their 
relationships with sequences that have been isolated from beef cattle in New Zealand as well 
as other cattle populations around the world. The general discussion in Chapter 4 will 
summarise the overarching findings of the thesis, including the limitations, and suggested 
directions for further research into BVDV.  
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2. The evolution and application of diagnostic tests for bovine 
viral diarrhoea virus in cattle: A non-systematic review 
2.1 Abstract 
Bovine viral diarrhoea (BVD) is an economically significant disease of cattle with a global 
distribution.  Several European countries have already gained success in eradicating BVD by 
strategically applying diagnostic tests as well as other disease control measures through 
coordinated national control programmes.  However, it is difficult to apply these frameworks 
to other countries where differences in the population demographics and regulatory policies 
create unique logistical challenges.  Having up-to-date information on the methodologies and 
performance of the current diagnostic tests is important for informing decisions about. The last 
formal review of bovine viral diarrhoea virus (BVDV) diagnostic tests was performed more 
than 15 years ago and there have been many advances in the field since then. The purpose of 
this non-systematic review was to highlight evolution and application of diagnostic tests in 
BVDV in cattle.  The first section reviews the epidemiology and pathogenesis of BVD 
highlighting important features relevant to diagnostic testing. Then chronological evolution of 
different BVD diagnostic tests starting with virus isolation in the 1940s and working through 
to the more advanced molecular methods in current use are presented along with an overview 
of the test methodology, test performance, and practical consideration.  The third section then 
discusses how these tests have been applied in different individual-level, herd-level, and 
industry-level control programmes.  Lastly, the discussion highlights key remaining technical 
gaps with the current BVD diagnostic tests to provide guidance on directions for future 
research.     
2.2 Introduction  
Bovine viral diarrhoea (BVD) is an economically important infectious disease that is 
widespread in cattle industries throughout the world causing significant impacts on animal 
health, welfare and production (Chang et al., 2021; Houe, 1999b; Pinior et al., 2017). The 
economic losses from BVD infections in cattle herds depend on the underlying level of herd 
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immunity, severity of the clinical signs, duration of infection, and interactions with other 
pathogens (Santman-Berends, Mars, van Duijn, & van Schaik, 2015). Recent studies have 
estimated that the production losses associated with BVD could be up to $687.80 US dollars 
(USD) per animal (Pinior et al., 2017). The disease is primarily spread and maintained in cattle 
populations by a small number of persistently infected (PI) animals that are created when the 
fetus gets infected during the mid-stages of pregnancy following an acute infection in the dam 
(Sasha R. Lanyon, Fraser I. Hill, et al., 2014). Since these PI animals shed large amounts of 
virus for life, finding and eliminating them from infected herds is key to getting BVD under 
control. This phenomenon has been highlighted through the successful BVD control 
programmes in the Scandinavian countries where there has been rigorous detection and 
elimination of PI animals (Laureyns, Ribbens, & de Kruif, 2010). 
One of the key factors behind the success of BVD eradication programmes is the availability 
of good diagnostic tests that can accurately determine the exposure and infection status of 
individual animals and herds (Gates, Han, et al., 2019).  Like many other infectious diseases, 
BVD does not have pathognomonic clinical signs and so diagnosis relies heavily on laboratory 
tests that either look for antibodies (Ab) against bovine viral diarrhoea virus (BVDV) as an 
indication of previous exposure or for viral genetic material or virus-induced antigens (Ag) as 
an indication of active infections (Sandvik, 1999). In some national eradication programmes 
such as the one currently implemented in Scotland, serological screening tests (Ab ELISA) are 
performed first to identify herds that are likely actively infected with BVDV and should be 
targeted for further investigation to identify PI animals (Metcalfe, 2019).  Other countries such 
as Germany, Belgium, and Ireland simply test all individual animals after birth rather than 
using serological screening (Lindberg & Alenius, 1999). Since PI animals can only be created 
before birth, once an animal tests negative for BVDV, it can be certified as non-PI for life.   
The success of any BVD control programme depends on the performance of tests at the both 
individual animal and herd level, which is in turn affected by choosing the right animals, 
samples, tests, and frequency of testing as well as making the correct epidemiological 
inferences about the test results. Although there have been previous review articles about 
BVDV diagnostic testing strategies (Houe, Lindberg, & Moennig, 2006; Jeremiah T. Saliki & 
Dubovi, 2004b), the last review was published 15 years ago and there have since been many 
advances in diagnostic test methodologies as well as better understanding of pathogenesis of 
BVD.  In this review, we first summarise key epidemiological features of BVD relevant to 
diagnostic testing (Section 1).  We then provide an overview of the key milestones in BVDV 
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diagnostic test development over the past eighty years and how these contributed to our 
understanding of BVD epidemiology and control (Section 2). We then discuss the performance 
and application of these tests at the animal, herd, and industry levels to support BVD control 
(Section 3) Finally, we discuss the remaining technical knowledge gaps that will improve 
understanding of BVD control (Discussion). 
2.3  BVD epidemiology and pathogenesis 
BVDV is a member of family Flaviviridae and genus Pestivirus. The pestiviruses comprise a 
positive sense, single stranded RNA genome of approximately 12.5 kb in length is flanked at 
either end by 5’ and 3’ untranslated regions (5’UTR, 3’UTR) (Meyers & Thiel, 1996; Tautz et 
al., 2015; Vilček et al., 2001). The 5’UTR contains both highly conserved and variable regions, 
which has allowed the development of both pan-pestivirus and species-specific molecular 
diagnostic assays (Ridpath & Bolin, 1998; Toplak, Sandvik, Barlic-Maganja, Grom, & Paton, 
2005). The virus contains one long open reading frame (ORF) that is translated into a 
hypothetical polyprotein of approximately 4000 amino acids which is post-translationally 
cleaved by viral and cellular proteases to  four structural (C, Erns, E1, E2) and eight non-
structural proteins (Npro, P7, NS2, NS3, NS4A, NS4B, NS5A, NS4B) (Richard E. Booth, 
Thomas, El-Attar, Gunn, & Brownlie, 2013b). E2 is a highly-variable, immunologically-
dominant glycoprotein in pestiviruses and the main target of neutralizing antibodies (Yesilbag 
et al., 2017). 
Pestiviruses are highly variable both antigenically and genetically, thus each is further 
classified into distinct species and genera. BVDV-1 is the most widespread species, and 21 
genotypes of BVDV-1 (BVDV-1a to BVDV-1u), three genotypes of BVDV‐2,  and four 
genotypes of HoBi‐like pestivirus have been reported (Yesilbag et al., 2017).  Depending on 
the physical presentation in cell cultures, there are two bio types: cytopathic (cp) and non-
cytopathic (non-cp) besides cp biotypes induce apoptosis in cultured cells when non-cp 
biotypes do not cause cell lysis (Gamlen et al., 2010).   It should be noted that in the recent 
updates of International Committee on Virus Taxonomy (ICVT), BVDV-1, BVDV-2 and 
HoBi-like pestivirus or BVDV-3 were re-named as Pestivirus A, B and H, respectively 
(Anonymous, 2020). However, to keep the terminology consistent with previous reports, the 
previous names were retained for use in this review.  
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The pathogenesis and epidemiology of BVD have several important features that are important 
for ensuring the tests are applied in a manner that will maximise performance.  For susceptible 
animals, the most frequent route of natural infection is by oronasal uptake of virus from 
persistently infected (PI) animal.  The exposure of naive immunocompetent cattle to non-cp 
BVDV strains results in transient infections (TI) where the virus is shed in most secretions 
from day 4 to day 10 post-infection with a measurable antibody response produced within 
2 weeks of the initial infection (Sasha R. Lanyon, Fraser I. Hill, et al., 2014; A Meyling, Houe, 
& Jensen, 1990).  The antibodies produced by the recovered animals provide a long term 
immunity against the particular BVDV strain (Gates, Evans, et al., 2019; Potgieter, 1995).  
Transplacental infection is a common event in pregnant cattle exposed to BVDV.  During the 
first 18 days of the pregnancy, the fetus is unattached and no embryonic infection can occur as 
BVDV does not penetrate the zona pellucida (Moennig & Liess, 1995). After the development 
of cotyledons (in between 29 to 41 days of post-conception), the virus can be transmitted from 
the infected dam to the fetus which may result in embryonic infection leading directly to 
embryonic death (Carlsson, Fredriksson, Alenius, & Kindahl, 1989). Infection of the dam 
during mid pregnancy between approximately 40 to 120 days of gestation can result in the birth 
of persistently infected (PI) calves (Brownlie, Hooper, Thompson, & Collins, 1998; Gates, 
Evans, et al., 2019). During this time, the fetus cannot develop sufficient innate or humoral 
immune response against the virus  and becomes immunotolerant to the infecting BVDV strain  
(Khodakaram-Tafti & Farjanikish, 2017).  After 125 days of  the gestation, the fetus is generally 
considered immunocompetent (Baker, 1995) and fetal infection at this time  results either  
clinically healthy or weak immunocompetent calf with or without congenital defects. In 
general, PIs shed large quantities of virus in their body secretions throughout their lifespan 
without developing antibodies while TI animals clear the virus within 2 to 3 weeks of the initial 
infection and develop antibodies against the infected virus strain that can persist and are 
detectable for long periods of time (Nettleton & Entrican, 1995).  
Maternal  antibodies play an important role in protection from BVDV infection in neonatal 
calves (Goyal & Ridpath, 2005).  New-born calves get passive immunity through ingestion and 
absorption of maternal antibodies from colostrum of the dams that have recovered from natural 
infection or produced antibodies in response to vaccination. The duration that passively derived 
antibodies remain in the animal is dependent on the amount of antibodies ingested, intestinal 
absorption, and the subsequent rate of decay with time (Robert W. Fulton et al., 2004).  One 
study reported that BVDV antibodies decayed to undetectable by 105–230 days of age 
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(Kendrick & Franti, 1974) while another study indicated that the mean time to for calves to 
become seronegative was 192 days of age (Robert W. Fulton et al., 2004). In general, the 
natural immunity from maternal antibodies remains until age of 6 months (Houe, 1994) but can 
sometimes last for up to 10 months (Gates, Evans, et al., 2019).  
Vaccination is another way of giving passive immunity to protect the animals from transient 
or fetal infection.  The overall goal of vaccination is to increase herd immunity so that the 
incidence of clinical disease and the birth of PI animals are reduced in the herd as a whole.  
Both modified live and inactivated vaccines are used worldwide and antibodies are detectable 
2 to 3 weeks post vaccination and rises until levelling off at 10 to 12 weeks post vaccination 
(Griebel, 2015; Ridpath, 2013).  Estimates of vaccine efficacy in preventing fetal infections 
varies from 50 to 100% in the literature with an average of approximately 80 to 90% (Goyal & 
Ridpath, 2005).  While some studies suggest that active infection of BVDV by natural 
infections or vaccinations can  prolong persistence of maternally derived antibodies (Robert 
W. Fulton et al., 2004; Muñoz-Zanzi, Thurmond, Johnson, & Hietala, 2002), others have 
highlighted that maternally derived immunity may block serum antibody responses against 
modified live virus vaccines or inactivated vaccines (J. Ellis, West, Cortese, Konoby, & 
Weigel, 2001; Robert W. Fulton et al., 2004).  This is the underlying reason why the vaccine 
label recommends waiting until calves are over 3 to 4 months of age before giving the vaccine.  
Similar to most other infectious diseases, the diagnostic tests for BVD can broadly be divided 
into two categories: (1) those that determine whether the animal is actively infected (virus‐
specific antigen, viral RNA or the virus itself) and (2) those that determine if the animal has 
previously been infected with the virus (virus-specific antibodies) (Jeremiah T. Saliki & 
Dubovi, 2004a).  Table 2.1 shows the animal-level interpretation of positive and negative 
results for these diagnostic tests.  It should be noted that vaccination and maternal antibodies 




Table 2.1 The epidemiological status of animals based on the results from antibody and 
virus testing regarding BVDV 
 Virus positive Virus negative 
Antibody positive 
• TI animals in the later stages 
of infection 
• PI animals with maternal 
antibodies 
• Vaccinated animals 
• Calves age < 10 months 
• TI animals after 2weeks 
of initial infection 
Antibody negative 
• PI animals  
• TI animals in the early 
stages of infection 
• Naive animals 
2.4 History of BVD diagnostic test development 
The diagnostic tests for BVD have evolved significantly over time since the disease was first 
recognised in the 1940s as highlighted in the timeline for Figure 2.1.  In particular, there has 
been a marked shift from diagnostic techniques that were used mainly to confirm individual 
clinical cases towards those that allow easier monitoring of herd-level BVD status (Houe et al., 
2006).  In the remainder of this section, we provide a review of the different methodologies, 




Figure 2.1 Evolution of diagnostic tests and milestones of BVDV 
2.4.1 Virus Isolation 
The first clinical case of BVD was recognised in 1946 and the virus was subsequently isolated 
in cell cultures to learn more about its properties. Virus isolation was considered the most 
reliable virus detection technique at the time and became the gold standard for BVDV 
diagnostic tests because of the high specificity (Jeremiah T. Saliki & Dubovi, 2004a).   A wide 
range of biological samples can be used to isolate the virus including whole blood, nasal 
discharge, serum, buffy coat, spleen, lungs, fetus, and semen.  The best samples for virus 
isolation from live animals is from mononuclear cells in the buffy coat obtained from whole 
blood while the best samples from necropsy are  tissues from the lymphoid organs such as 
spleen, thymus, Payer’s patches, and mesenteric lymph nodes (Brock, 1995; Jeremiah T. Saliki 
& Dubovi, 2004a).  The principle of this testing method is to allow virus in the testing sample 
to grow in a cell culture following isolation and the identification of the virus.   Many different 
cells of bovine origin that support the growth of this virus have been described elsewhere 
(Sandvik, 1999), but bovine turbinate (BT) cells are widely used for virus isolation as they are 
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more sensitive to BVDV-induced cytopathic effects that facilitate to differentiate cp from non-
cp strains (Goyal & Ridpath, 2005). 
In virus isolation, the cell culture plates are inoculated with the sample and are kept in 370C for 
4 to 5 days for BVDV isolation. After incubation for 4 days, the cells are fixed with 20% 
acetone in phosphate-buffered saline (PBS).  The cytopathic effect can be observed by phase 
contrast microscope if the sample contains cp biotype (Sandvik, 1999).  However, as the 
majority of BVDV isolates are of the non-cp biotype and cell cultures should be further tested 
to detect presence of non-cp BVDV strains. This involves fixing and incubating with 
fluorochrome or enzyme labelled BVDV-specific antibodies to recognize the presence of non-
cp BVDV (Brock, 1995). Isolated virus can be confirmed by either direct fluorescent antibody 
assay (DFA), immunoperoxidase, ACE or RT-PCR.   
The most common use of virus isolation is currently as a gold standard to evaluate the 
sensitivity and specificity of other BVDV diagnostic tests (Belak & Ballagi-Pordany, 1991; S. 
R. Bolin & Ridpath, 1998; Drew, Yapp, & Paton, 1999; Hamel, Wasylyshen, & Nayar, 1995; 
R. Renshaw, R. Ray, & E. Dubovi, 2000; Shannon, Richards, Kirkland, & Moyle, 1991). Virus 
isolation is rarely used in surveillance programmes since the test has several limitations as a 
diagnostic test. Virus isolation requires specialised cell culturing facilities, is time and labour 
intensive and careful quality control is required to ensure that the cultured cells and fetal serum 
used as medium supplement are free of BVDV and its antibodies (Houe et al., 2006). 
Furthermore, virus isolation is not suitable for detecting  young PI animals less than 3 months 
old because maternal antibodies against BVDV from colostrum can adhere to the virus particles 
making penetration of cell cultures impossible resulting in false negative test results that 
directly affects the test sensitivity as well (Dubovi, 2013; Sandvik, 1999; Zimmer, Van 
Maanen, De Goey, Brinkhof, & Wentink, 2004).  However, there are some disagreements 
regarding considering VI as the gold standard for the virus detection because the test sensitivity 
is highly depend on the purity of the fetal serum used as a supplement for the cell culture and 
the sensitivity of a given cell culture system. Fetal calf serum used as a supplement of the cell 
culture medium should be free from both BVDV and BVDV specific antibodies and further 
the sensitivity of a given cell culture system will primarily depend on the volume of the 
inoculum and the period of incubation.  
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2.4.2 Immunofluorescence  
As discussed above, one of the major limitations with viral isolation is VI technique cannot 
identify non-cp BVDV without a help of another diagnostic test. At the time of BVDV was 
firstly identified, the confirmatory diagnoses BVDV were originally depended upon 
transmissions of the disease by calf inoculations to detect and titrate the tissue culture-produced 
virus or plaque inhibition assays which the cytopathic effect of cp-BVDV was inhibited by 
non-cp virus as there were no other way of identifying non-cp BVDV (Albert L Fernelius, 
1964). Immunofluorescence was firstly applied to healthy PI animals to demonstrate 
widespread distribution of viral antigen in brain and spinal cord neurons, renal glomeruli, renal 
tubules, lymph nodes, spleen, small intestine crypts, testicular tubules, and endothelial cells 
With fluorescence antibody test (FAT), the detection of non-cp BVDV from biological 
specimens was made much easier (Goyal & Ridpath, 2005). 
Immunofluorescence has been used for the direct detection of infectious agents in tissue 
samples and the test is called direct fluorescent antibody test (DFA). In this procedure, cryostat 
sections of fresh tissues or smears of buffy coat cells are stained with fluorescein conjugated 
anti-BVDV antibody and then examined under a fluorescent microscope. The stained cells are 
examined under a fluorescent microscope to identify positive cells that are characterised by 
apple green fluorescence (Goyal & Ridpath, 2005). In later adaptations of the methodology, 
DFA was performed using BVDV specific monoclonal or polyclonal antibodies. However, 
monoclonal antibodies (mAb) were preferred since that could produce clear FA stain 
preventing nonspecific background staining.  It is important that the mAbs used for the test are 
broadly reactive against all BVDV strains to prevent false negative results. There are only a 
few mAbs that have ability to broadly react against all BVDV strains (Jeremiah T. Saliki & 
Dubovi, 2004a). 
The main applications of immunofluorescence techniques since they were first introduced in 
the 1960s have been use for the confirmation of non-cp BVDV strains from virus isolation and 
as another gold standard test to evaluate the sensitivity and the specificity of other BVDV 
diagnostic approaches (Coria, McClurkin, Cutlip, & Ritchie, 1975; A. Fernelius, 1969; Lopez, 
Osorio, & Donis, 1991; Magar, Minocha, Montpetit, Carman, & Lecomte, 1988; Maisonnave 
& Rossi, 1982; Roberts, Etchison, & Bond, 1988; Ruckerbauer, Girard, Bannister, & 
Boulanger, 1971). The test has been optimized and developed to apply for the pooled and 
individual field samples in late 1970s (Ayanwale, Fahrmann, Johnson, Anderson, & Kaneene, 
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1979). Initially indirect immunofluorescence has been used for the detection of anti-BVDV 
antibodies however, ELISA and VN tests appear to have replaced the indirect FAT afterwards 
considering the cost, time and experienced staff (A. L. Fernelius & Packer, 1969) .   The main 
limitations of DFA are that is that it is agent specific and can only be performed on fresh 
samples (Dubovi, 2013). 
2.4.3 Serum Neutralization 
Virus neutralisation (VN) also known as serum neutralisation (SN) is used as the gold standard 
test for the detection of anti-BVDV antibodies. The first cp-BVDV was isolated in 1960 and 
that allowed the development of serum neutralization and plaque neutralization assays and this 
allowed characterization of the antigenic differences of BVDV (Goyal & Ridpath, 2005).  The 
standard test procedure for VN is described extensively elsewhere (Rossi & Kiesel, 1971).  The 
basic steps of VN involve performing two-fold serial dilutions of serum samples that are then 
incubated with a known amount of the virus followed by the addition of indicator cells.  The 
test is read after 4-5 days of incubation and the highest dilution of the serum that inhibits virally 
induced cytopathic effects in approximately 50% of inoculated cells is considered to be the 
antibody titre of the serum (Goyal & Ridpath, 2005).  A schematic illustration of the test 
procedure is shown in figure 2.2. The infectivity for the cp strains is detected by using an 
inverted light microscope and the infectivity for the non-cp strains is detected by IPMA (R W 
Fulton et al., 1997).   
 




VN tests are species independent and cross-neutralization tests can be used to characterize 
antigenic differences among pestiviruses (Dekker, Wensvoort, & Terpstra, 1995).  The 
causative agent for mucosal disease was first recognized as BVDV in early 1960s using virus 
neutralizing antibodies (Gillespie, Coggins, Thompson, & Baker, 1961; Thomson & Savan, 
1963).  The primary use of VN is to determine  types of BVDV and to differentiate  the 
antigenic diversity among BVDV sub types (R W Fulton et al., 1997) as it is the only test that 
can assess antibody status with regard to strain variations of BVDV isolates. A panel of 
monoclonal antibodies (mAb) were produced for BVDV using structural and non-structural 
viral genome proteins in early 1990s (S. Edwards, Moennig, & Wensvoort, 1991).  Using SN 
tests and the difference in  cross reactivity of mAbs to the different viral proteins, a considerable 
antigenic diversity among BVDV isolates was demonstrated (Corapi et al., 1990). For example, 
the cross reactivity of mAbs to the NS3 (a highly conserved non-structural protein of BVDV) 
was observed with all the pestiviruses but the envelope proteins E2 and Erns appeared to be  
more specific for the viral species (S Edwards, Sands, & Harkness, 1988) 
One of the most common uses for virus neutralization is to determine vaccine efficiency against 
different circulating BVDV strains.  For example, cross-neutralization assays were performed 
in 1997 to test the cross protection of US vaccines against circulating virus strains in Germany.  
These studies revealed no significant differences between American and German strains thus 
indicating that protective vaccines may contain the same strains in these countries (Wolfmeyer 
et al., 1997). SN tests have also been used to differentiate  the antibody titres that were produced 
by active infection or  from vaccination because active BVDV infection  by demonstrating a 
fourfold rise in antibody titres using paired serum samples (Goyal & Ridpath, 2005). The SN 
tests give endpoint values which may be more biologically relevant than ELISA and the SN 
test is the only one that can assess antibody status regarding the strain variations that exist 
among BVDV isolates. 
One of the main limitations with VN tests as currently deployed is the significant variation that 
exists in test results between different diagnostic laboratories, which occurs because 
laboratories often use locally developed cell systems and different strains of virus without set 
standards for performing the test. For this reason, it is important that tests conducted on acute 
and convalescent sera are conducted at the same diagnostic laboratory to ensure that any 
changes in absolute antibody titres between time points are not simply due to differences in 
laboratory methodology (Dubovi, 2013).  An additional limitation is that VN tests are labour 
intensive requiring experienced staff and well equipped laboratories to perform the test 
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(Sandvik, 2005a), which makes it less cost-effective when laboratories are processing only few 
or sporadic sample submissions (Sandvik, 1999).  
2.4.4 Immunoperoxidase 
The next advancement in BVDV diagnostic tests came through the introduction of the 
immunoperoxidase monolayer assay (IPMA) in the 1980s (A. Meyling, 1984) that gave 
diagnostic laboratories the ability to test many serum samples for BVDV at the same time. The 
technique was developed for the detection of BVDV in tissues of infected animals. Initially, 
anti-BVD-virus serum for the IPMA was developed by inoculating laboratory animals. 
Monoclonal antibodies (mAb) against BVDV were developed in 1985  and thereafter BVDV 
specific mAbs were used as anti-BVDV-antibodies (Peters, Greiser-Wilke, Moennig, & Liess, 
1986; G. H. Smith, Collins, Carman, & Minocha, 1988; Van Zaane, 1984).  Monoclonal 
antibody based IPMA has been compared with polyclonal antibody IPMA  and the relative 
sensitivity and specificity  of monoclonal antibody based IPMA have been estimated at close 
to 100% (Deregt & Prins, 1998). Monoclonal antibodies have been chosen because of their 
broad reactivity, antigenic avidity to different BVDV proteins and lack of competition for 
binding sites or binding to unusual BVDV isolates (Deregt & Prins, 1998).    
For immunoperoxidase assays, the cell cultures are inoculated and incubated with the BVDV 
suspected sample and then the anti-BVDV-antibodies or BVDV specific monoclonal 
antibodies are added for antigen antibody reaction. Then peroxidase -labelled conjugate is used 
as an immunoperoxidase test to confirm the presence of virus after which the stained cells are 
examined under light microscope. A developing red colour indicated a positive reaction for 
infectivity (R W Fulton et al., 1997; Goyal & Ridpath, 2005). Immunoperoxidase tests have 
some advantages over DFA because Immunoperoxidase can be performed on a large number 
of samples at once because 96 well assay plates can be used for the test and as the results are 
read by eye, the assay does not require a fluorescent microscope (Brock, 1995). The 
immunoperoxidase test is very accurate and reliable for detecting PI animals that are shedding 
the virus in concentrations that are up to 100 times greater than the viral loads in acutely 
infected animals.  Although this method is not considered to be sensitive enough for diagnosis 
of acute BVDV infections, this is not a major limitation for control programmes where the 
focus is on detecting PI animals rather than TI animals (Sandvik, 2005a).   
The primary uses of IPMAs have been (1) for determining the virus titre in cell cultures 
initially, (2)  in conjunction with virus isolation (VI) to detect non-cp BVDV (G. H. Smith et 
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al., 1988), (3) for detection of BVDV contamination in either cell cultures or virus stocks have 
been previously reported (Castro, Stoffregen, Brigman, & Hillard, 1997), and (4) certification 
of BVDV free bovine semen for artificial insemination and trading purposes (Afshar, Dulac, 
Dubuc, & Howard, 1991). The assay has also been used to detect non-cp strains in their study 
populations (R W Fulton et al., 1997).    
2.4.5 Immunohistochemistry 
Immunohistochemistry (IHC) is another method used for direct Ag detection and used for 
formalin fixed tissue samples. The first IHC was developed in the early 1980s using paraffin 
wax embedded tissue sections biopsied from calves with mucosal disease (Ohmann, 1983). 
The main advantage of IHC is that this technique can be performed on many different tissue 
samples collected through necropsy such as thyroid gland, skin, oral mucosa, oesophagus and 
abomasum samples (Goyal & Ridpath, 2005).  The methodology for IHC has been described 
extensively elsewhere (Wilhelmsen, Bolin, Ridpath, Cheville, & Kluge, 1990).  Briefly, the 
basic steps involve fixing the tissue samples in paraffin wax, mounting a thin slice of paraffin 
embedded tissue on a slide, and deparaffinizing the sample. Next a specific antibody is applied 
to the sections to bind to the target epitope prior to chromogenic staining. Peroxidase or alkaline 
phosphatase staining is done with biotinylated secondary enzyme linked antibody, a substrate 
is added at the end, and the slide is viewed under the microscope. 
In the 1990s, skin biopsies were tested with IHC using panel of mAbs on cryostat sections of 
skin and this was proven to be a fast and reliable alternative to the conventional virologic 
methods for the diagnosis of BVDV infection (Thür, Zlinszky, & Ehrensperger, 1996). The 
ability to perform IHC on skin specimens from live animals resulted in its wider uptake for 
BVDV diagnosis. Similar to IPMA, however, it has been shown that while IHC staining for 
BVDV in formalin-fixed, paraffin-embedded skin is an effective method for the diagnosis of 
PI cattle, it has limited ability to detect transiently infected animals (Njaa, Clark, Janzen, Ellis, 
& Haines, 2000). IHC has been proposed as an alternative test to the rapid virus isolation 
method, which utilizes serum as the inoculum for cell cultures in microtiter plates (Brodersen, 
White, & Smith, 1998). The diagnostic sensitivity and specificity of IHC have been compared 
with other BVDV diagnostic tests and IHC has shown the best performance with high 
sensitivity (97%-100%) and specificity (97%-98.8%)  (Cornish et al., 2005; J. A. Ellis, Martin, 
Robert, & Haines, 1995). In particular, one of the main advantages of using IHC on skin 
samples is that it can be used to screen neonatal calves for persistent BVDV infection since 
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maternal antibodies do not interfere with the test methodologies (Grooms & Keilen, 2002). 
However, IHC is a highly labour-intensive process and takes considerable time to get test 
results, which has limited its current use to support BVD management programmes. 
2.4.6 Antibody ELISA 
Enzyme link immunosorbent assay (ELISA) was developed in the 1980s as another 
methodology to identify animals with previous exposure to BVDV which provided some 
additional advantages over SN for detecting BVDV antibodies particularly with regards to time 
and cost  (Howard, Clarke, & Brownlie, 1985).  When the first Ab-ELISAs to be developed 
were compared with SN tests, there was 97% agreement between the two tests suggesting 
similar levels of performance (Bock, Burgess, & Douglas, 1986) .  Two ELISA techniques 
were developed in 1987: an indirect ELISA and a competitive ELISA to detect antibodies 
against BVDV.  This marked the first time that monoclonal antibodies were used for an ELISA 
to detect BVDV and the results showed 100% agreement with SN test results (Juntti, Larsson, 
& Fossum, 1987).  Non-competitive and competitive/blocking ELISAs are currently the two 
main ELISA techniques that are used to detect Abs against BVDV (Schrijver & Kramps, 1998). 
The test procedures are described extensively elsewhere (Bhatia, Sood, Mishra, Pattnaik, & 
Pradhan, 2008; Howard et al., 1985) and a simple illustration of test procedures are shown  in 
figure 2.3.  In non-competitive ELISA, specific Abs in the test sample that have been bound to 
the immobilized Ag are detected by enzyme conjugated IgG-specific Abs. The Ag could be 
either a whole virus antigen, a non-structural protein, or a peptide. In this test, the amount of 
Abs bound to antigens is directly proportionate to the enzyme-mediated colour development. 
In the blocking ELISA, the antibodies present in the sample compete with agent-specific 
enzyme conjugated antibodies for binding to a specific amount of immobilized antigen.  The 
degree to which the antibodies in the test sample prevent binding of an agent-specific enzyme-
conjugated Ab is measured. The amount of Ab in the test sample that is bound to the Ag is 





Figure 2.3 Illustration for Ab-ELISA procedure  
The Ab-ELISA results can be influenced by the sample type, antigen used for the test, and the 
conjugated antibodies (Schrijver & Kramps, 1998). The procedure used to prepare the Ag can 
also affect the specificity and the sensitivity of the test (Goyal & Ridpath, 2005). The most 
immunogenic proteins of BVDV used for indirect ELISA are Erns, E2, and non-structural 
protein 3 (NS3) (Collett, 1992). The specificity of serodiagnosis has been enhanced greatly by 
the use of antigen specific monoclonal antibodies (MoAb) in competitive ELISA systems (S. 
Bolin, Moennig, Kelso Gourley, & Ridpath, 1988) the best use  NS3 mAbs which have shown 
high sensitivity compared with SN for bovine and ovine serum types (Paton, Ibata, Edwards, 
& Wensvoort, 1991). The test specificity has been further improved through the use of Ags 
that are derived from recombinant DNA techniques (G. H. Smith et al., 1988).  
Currently, commercially available Ab ELISA kits are widely used to detect BVDV Abs.  These 
test kits reduce inter- and intra-laboratory variations by standardizing the methods and reagents 
used (Dubovi, 2013). Serum, plasma or milk samples can be used as sample types to detect 
Abs against BVDV (Beaudeau, Belloc, Seegers, Assié, Sellal, et al., 2001). ELISA tests have 
more utility due to fast test results, cost effectiveness, and the independence of cell cultures for 
the test (Sandvik, 1999). However in general Ab-ELISA has been proven to achieve fair 
sensitivity and the specificity of 99% and 98% in respect to SN tests and highly recommended 
as a diagnostic test (Sasha R. Lanyon, Fraser I. Hill, et al., 2014).   
The main limitation to the Ab-ELISA is that is not possible to distinguish between antibodies 
produced in response to natural exposure to BVD virus and those acquired from colostrum or 
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vaccination (Evans et al., 2019). Therefore, it has been recommended that testing for antibodies 
should not be performed on animals under 10 months of age or on animals that have previously 
been vaccinated against BVD (Gates, Evans, et al., 2019).  
2.4.7 Antigen capture ELISA 
After BVDV specific MAbs became available in early 1990s, several antigen capture ELISAs 
(ACE) were developed for rapid detection of BVDV antigens extracted from different sample 
types such as blood, serum, milk and tissue samples (Sandvik, 1999).   ACE is known as a 
robust, simple, cost-efficient diagnostic method because it does not require cell culture 
facilities to perform the test, the test results are minimally affected by prolonged storage of the 
samples, and the test can generate a positive result even for samples with low concentrations 
of viral antigens.  Although the tests have high analytical sensitivity and specificity (>95%) 
(Brinkhof, Zimmer, & Westenbrink, 1996; Sasha R. Lanyon, Fraser I. Hill, et al., 2014; Mignon 
et al., 1992; J. T. Saliki, Fulton, Hull, & Dubovi, 1997; Sandvik & Krogsrud, 1995), the results 
can be influenced by concentrations of Ag in the sample, the specificity of the Ab reagent, the 
presence of highly conserved regions in the target Ag (Dubovi, 2013). 
The basic principle of ACE uses monoclonal Abs to capture viral Ag followed by detection of 
antigen-antibody complex with enzyme-conjugated Ab (Ludemann & Katz, 1994).  The test 
procedure is described extensively elsewhere (Sandvik & Krogsrud, 1995). Two BVDV 
proteins have been  identified as potential target antigens, NS3 (p80) and Erns (E0), but NS3 is 
preferred as it is highly conserved among all BVDV strains and BVDV specific monoclonal 
antibodies (Mabs) exist that recognize the target antigens (Dubovi, 2013). Antigen capture 
ELISAs (ACE) have been commercially produced to target NS2-3 protein, a highly 
immunogenic protein produced in large amounts in PI cattle (Brinkhof et al., 1996).   
The rapid diagnostic tests have been introduced by different pharmaceutical companies such 
as SNAP BVDV Antigen (Ag) Tests that can identify BVDV infected cattle in 20 minutes 
using ear notch samples. The primary value of these rapid pen-side tests is the ability to manage 
clinical cases. If the farm has an animal with clinical signs compatible with mucosal disease, it 
would be useful to rule out BVDV before treating the animal to reduce the risk of spread of the 
virus. The SNAP tests are also probably useful in situations where animals could be quickly 
screened to identify PI animals when buying or introducing a previously untested animal to the 
farm. Moreover, farmers can use this type of on-farm testing which may encourage them to 
test animals for BVDV and could be used simultaneously with animal identification programs.  
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This kind of rapid diagnostic test is very convenient for screening new-born calves, 
replacements heifers, and bulls in the farm without waiting a long time for laboratory test 
results.  
There are several limitations in the use of ACE to detect BVDV infected animals. Although 
the antigen capture ELISA has previously been considered as the test of choice for eradication 
programs, occasional false negative test results have been observed with calves that have high 
levels of colostral antibodies in their blood. In these cases, studies have shown that the maternal 
antibodies adhere to the surface of the virus which prevents antibodies used in the ACE from 
binding and leads to false negative results for a small number of likely low-shedding PI animals 
(Gates, Evans, et al., 2019; Goyal & Ridpath, 2005; Zimmer et al., 2004). It is therefore 
recommended not to use ACE for testing serum samples in calves less than 3 months of age 
(Dubovi, 2013). However, skin biopsies or ear notches are still considered acceptable for PI 
testing since the quantity of maternal antibodies in tissues is much lower than blood and ear 
notch samples are also convenient to collect at the same time as identification ear tags are 
placed (Cornish et al., 2005; Kuhne et al., 2005). 
2.4.8 Molecular methods 
Molecular studies have contributed to understand the epidemiology of BVDV. The basic 
principle of using molecular methods to diagnose BVD infections is the detection of viral 
nucleic acid from the animal specimens. Several molecular diagnostic tests have been described 
for the detection of BVDV infections starting in early 90s with radioactive filter hybridization 
probes (Sandvik, 1999) and progressing to reverse transcriptase-polymerase chain reactions 
(RT-PCR) in the early 2000s (Goyal & Ridpath, 2005; Jeremiah T. Saliki & Dubovi, 2004b).   
2.4.8.1 Reverse Transcriptase Polymerase chain reaction (RT-PCR) 
Detection of virus by RT-PCR has been found to be more rapid and sensitive than virus 
isolation with the added advantage that the test results are not affected by the presence of Abs 
in the test sample. RT-PCR has become a frequently used BVDV diagnostic nowadays and can 
be combined with genetic sequencing to provide a genetic profile or genotype. Genetic typing 
of pestiviruses has been mostly based on sequence comparisons of the 5’-UTR, Npro and E2 
regions (Vilček et al., 2001). It has been concluded that the 5'-UTR is the most conserved 
region in pestivirus genome (Vilček et al., 1998).  The first genomic sequencing of BVDV was 
done in 1980s and at the same time it was revealed that non-cp and cp strains of BVDV can be 
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distinguished by genetics (Donis, Corapi, & Dubovi, 1988) and many RT-PCR assays were 
developed in early 1990s.  
RT-PCR can be conducted on almost any sample taken from infected animal including blood, 
milk, follicular fluid, saliva, and tissue samples (Sasha R. Lanyon, Fraser I. Hill, et al., 2014). 
The principle of the test involves converting a portion of the viral RNA genome into 
complementary DNA (cDNA) using target specific DNA oligonucleotides, amplifying the 
cDNA through cycles of PCR and visualizing the product (amplicon) by gel electrophoresis. 
Prior to use in the PCR, viral RNA is chemically extracted from cellular material using 
commercial extraction kits or phenol-chloroform extraction.  The RNA is added to a PCR 
reaction mixture which contains reverse transcriptase enzyme, Taq polymerase enzyme, 
primers specific for the target of interest, and nucleotides. If the target RNA is present, the 
primers anneal to the RNA strand and then the reverse transcriptase enzyme synthesizes a 
complementary DNA strand extending from the primer. The Taq polymerase enzyme then 
amplifies the cDNA using multiple cycles of heating and cooling exponentially increasing the 
number of copies of DNA. The test procedure is described elsewhere (Vilček et al., 2001) and 
a simple illustration of test procedure of RT-PCR is displayed in figure 2.4. When first 
developed, a two-step (cDNA + DNA amplification)  two-tube RT-PCR assays  were used but 
more recently two-step one-tube RT-PCRs were developed in which cDNA creation and 
implication occurred in a single tube to minimize sample manipulation and contamination.      
 
 
Figure 2.4: Testing procedure for RT-PCR 
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2.4.8.2 Quantitative Reverse Transcriptase Polymerase chain reaction (qRT-PCR) 
The PCR technique was further advanced to develop nested PCR assays with two rounds of 
PCR to increase analytical sensitivity, and multiplex assays with species-specific primers for 
genotyping  (Goyal & Ridpath, 2005). Quantitative RT-PCR assays determine the actual 
amount of PCR products present in a given cycle. The probe based qRT-PCR requires a probe 
labelled with fluorescence that accumulates in each PCR cycle that measures at the end of the 
PCR (Jia, 2012). More recently, quantitative RT-PCR (qRT-PCR) using TaqMan probes  have 
been developed for rapid detection of BVD virus RNA  where sensitivity and specificity have 
been compared with RT-PCR and have found that  TaqMan qRT-PCR was 10-fold more 
sensitive and 100% specific (Bhudevi & Weinstock, 2001).    
Later, qRT-PCR assays were developed to test milk samples of dairy animals with 100% 
sensitivity compared with VI because  PCR test results are not affected by the presence of Abs 
in milk (Radwan, Brock, Hogan, & Smith, 1995). Since this technique offered high sensitivity, 
it was suitable to test specimens with potentially low quantities of virus, such as bulk milk, 
pooled samples of serum or plasma or other biological materials from transiently infected, as 
well as PI animals (Sandvik, 2005a). 
2.4.8.3 Phylogenetic Analysis of BVDV Genomes 
The variations of the virus strains within and between farms, viral evolution  and transmission 
patterns have been studied in many countries (Hamers, Lecomte, Kulcsar, Lambot, & Pastoret, 
1998). (Vilček et al., 2001). Phylogenetic analyses has  provided more detailed information 
than studies based on reactions with antibodies and has allowed the rapid detection and 
discrimination of BVDV-1 and BVDV-2 sub genotypes, as well as the identification of novel 
sub genotypes (Yesilbag et al., 2017). 
There are some limitations for molecular diagnostics. For example, a positive RT-PCR does 
not define the clinical status of an animal as RT-PCR assays detect acutely infected animals, 
PI animals, and animals vaccinated with modified-live vaccines. Therefore follow-up testing 
is necessary to define the status of positive animals (Dubovi, 2013). In addition, although PCR 
can use variety of sample types, the efficiency of the nucleic acid extraction of the specimen 
depends on the sample type and viral load within the sample (Sasha R. Lanyon, Fraser I. Hill, 
et al., 2014).  
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2.5 Application of diagnostic tests to control BVDV at the herd level 
The goal of most herd-level BVD control programmes is to eliminate any existing PI animals 
from the herd and then take measures to prevent the re-introduction of BVDV from outside 
sources through improved on-farm biosecurity. A BVDV positive herd is defined as a herd that 
has at least one transiently infected or persistently infected animal present amongst the calves, 
replacement heifers, mixed-age cows, bulls, foetuses, and/or other fattening cattle on the 
premises.  When trying to eliminate the virus from herd, it is usually necessary to determine 
the BVD status of all individual cattle through diagnostic testing since there are no 
pathognomonic clinical signs and PI animals are indistinguishable from their unaffected herd 
mates. However, testing all individual animals is often prohibitively expensive and logistically 
challenging to perform especially in large herds and herds that are raising large numbers of 
stock for fattening.  Alternate testing strategies have been proposed that first use serological 
screening tests to determine whether cattle in the herd or in separately managed groups within 
the herd have previously been infected with BVDV.  If the whole herd test negative for 
antibodies against BVDV, there are unlikely to be PI animals present and no further action is 
required. If there is serological evidence of active infections, individual animals in seropositive 
management groups can then be individually tested to find and eliminate PI animals.  In dairy 
herds, bulk tank milk (BTM) is a convenient sample that allows screening of the herd both for 
antibodies and for virus to simultaneously determine both the exposure status and infection 
status of the milking herd, respectively.  
In this section, we first review the main serological screening tests used to evaluate herd-level 
BVD status including (1) individual antibody ELISA (spot test), (2) pooled serum antibody 
ELISA, and (3) bulk milk antibody ELISA (Houe et al., 2006). We then review the strategies 
that are used to perform PI hunts in herds with serological evidence of active infections 
including (1) individual animal testing use ACE or PCR and (2) bulk milk PCR. 
2.5.1 Serological screening tests 
The majority of herds with PI animals that have been mixing with susceptible cattle for long 
periods of time are expected to have a large percentage of animals with high antibody levels 
against BVDV.  The seroprevalence of BVDV in affected herds has been estimated from  60% 
to more than 90% of the cattle population across numerous published studies (Han J-H, 2018; 
Houe, 1999b; Scharnbock et al., 2018; G. Thobokwe, C. Heuer, & D. P. Hayes, 2004; Voges, 
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2008). In contrast, only 1-2% of animals in an infected herd may be shedding virus at any given 
time and it is possible for PI animals to have died or been culled   by the time PI hunt is 
performed (Houe, 1999b; Sasha R. Lanyon, Fraser I. Hill, et al., 2014). Therefore, serological 
tests are generally more sensitive and cost-effective to use as initial screening tests to determine 
whether there is evidence of active BVDV transmission within the herd. Previous studies have 
shown a strong positive correlation between the seroprevalence of BVDV and the likelihood 
of finding at least one PI animal on subsequent PI hunts (Richard E. Booth & Brownlie, 2016; 
Lanyon, McCoy, Bergman, & Reichel, 2014; Weir, 2016).  
2.5.1.1 Individual Serum Ab-ELISA (Spot Test) 
The spot test is an application of individual serum Ab-ELISA that is commonly used to estimate 
the seroprevalence of BVDV in tested herds (Houe et al., 2006). This screening test involves 
randomly selecting 5 to 10 animals from a management group and performing individual Ab-
ELISA on serum samples from each animal (Houe, 1994; Lindberg & Alenius, 1999). Animals 
that have only recently been introduced into the herd should be excluded since there may not 
have been enough time for BVDV to spread and cause an Ab response (Houe et al., 2006). It 
is also important that the animals are unvaccinated and over 10 months of age to prevent false 
positive results. Since BVDV antibodies can persist for a long time in recovered animals, the 
test is most often performed on animals between 10-18 months of age to give a more accurate 
picture of the current infection status rather than more historical infections.  When the tests are 
being used to make inferences about herd BVD status, it is recommended that the test be 
performed for each separate management group (defined as groups of cattle that have direct 
nose-to-nose contact with each other). 
A positive result on an individual test indicates that the animal has previously recovered from 
a BVDV infection and it is not a PI animal (Houe, 1994).  Various cut-off points have been 
suggested to then classify herds as being BVDV positive or negative based on the total number 
of animals in the sample that returned positive test results. Recent modelling work suggest that 
the optimal cut-off point appears to be 20% positive animals (Humphry, Reeves, & Gunn, 
2018), which is agreement with recommendations published elsewhere (Richard E. Booth & 
Brownlie, 2016; Houe, 1999b).  The herd sensitivity and the specificity for spot testing have 
been calculated as 93% and 100%, respectively (Richard E. Booth & Brownlie, 2016).  
However, the results may not be as accurate if the PI animals were only recently introduced 
into the group or if there are pregnant cattle carrying PI calves (Houe et al., 2006).  Although 
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10 animals are often used as the standard sample size, reducing these numbers does not appear 
to have a significant effect on the herd-level test performance provided an appropriate cut-point 
is chosen (Humphry et al., 2018)., For example,  a BVD eradication programme in Netherland 
has performs antibody spot-testing on five animals (Humphry et al., 2018) and it has been 
suggested that as few as three young stock might need testing especially if the antibody test is 
done in tandem with antigen testing (Lindberg & Alenius, 1999; Seki, Seimiya, Yaegashi, & 
Sato, 2006). Testing fewer cattle can make the test more affordable to farmers and potentially 
increase testing uptake in voluntary programmes. 
In addition to predicting the presence or absence of current infection, the spot test can also 
provide information on the time that has passed since the infection was last present.  All animals 
born after the removal of the last PI animal should theoretically be seronegative by the time 
they reach 10 months of age (Lindberg & Alenius, 1999).  However, false negatives can occur 
in herds where the PI calves died or were culled before they had the opportunity to infect 
sufficient numbers of animals in the group to meet the 20% cut-off value. These problems with 
misclassification can be avoided by repeating the spot test analyses 6 months later (Houe, 
1999b). It is recommended that herds with positive spot test results test all new-born animals 
for BVDV antigen to remove PI animals as soon as possible rather than waiting to see if there 
are rising titres that may provide stronger evidence of active BVDV transmission occurring in 
the group (van Duijn, Veldhuis, Mars, de Roo, & Lam, 2019). 
One of the significant limitations of spot testing in beef herds is the restriction that animals 
must be greater than 10 months of age at the time of sampling.  By the time the test can be 
conducted to determine PI animal was born into the calf crop and/or was one of the dams that 
calving season, it is already too late in the calendar year to implement appropriate vaccination 
and testing programmes to have prevented more dams from creating PI calves during the 
breeding season.  There are also additional logistical challenges in conducting sampling in beef 
herds since most calves are weaned at 6 to 8 months of age when they are too young to sample 
due to potential interference by maternal antibodies, and then minimally handled until 18 to 24 
months of age when the results are no longer a good indication of the current BVDV status of 
the herd.  For these reasons, it is often recommended that beef herds with a high risk of BVDV 
incursions use vaccination and/or calf testing as preventative control measures.  
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2.5.1.2 Pooled Serum Ab-ELISA 
Pooled serum Ab-ELISA is an extension of the spot test where individual samples from 10 to 
15 animals are combined into a single pooled sample for testing.  The test is commonly used 
for non-lactating stock such as youngstock, dry dairy stock, and beef cattle (Lanyon, Anderson, 
& Reichel, 2014; Sasha R. Lanyon, Fraser I. Hill, et al., 2014). This test has the advantage of 
potentially reducing testing costs by reducing the total number of Ab-ELISAs that must be 
performed at the diagnostic laboratory.  When selecting animals for the test, all the criteria that 
are followed for individual serum Ab-ELISA (unvaccinated animals greater than 10 months of 
age) should be followed to get an accurate test result. The total concentration of antibodies is 
reported as a single S/P (sample to positive) ratio with higher values indicating an increased 
likelihood of at least one PI animal being present in the group.  There is also a strong correlation 
between the S/P ratio and the seroprevalence of BVDV amongst the individuals contributed to 
the pool (Evans et al., 2019). 
The appropriate sample size for the pooled Ab-ELISA may vary depending on herd size (Sasha 
R. Lanyon, Malcolm L. Anderson, et al., 2014).  Previous studies have shown that pool size 
had no significant effect on the S/P ratio and pools of any size from 5 to 25 can be tested with 
the same interpretation (Sasha R. Lanyon, Malcolm L. Anderson, et al., 2014). However, the 
current recommendation is to collect serum samples from 15 animals (9 minimum) to provide 
a 95% of chance of finding a seropositive animal among 15 animals. There are three cut-off 
values used for interpreting the test results If the S/P ratio is < 0.17, animals in the group are 
unlikely to have been exposed to BVDV and it is very unlikely that there is a PI animal present. 
If the S/P ratio is between 0.17 and 0.75, animals in the group have been exposed to BVDV, 
but at lower contact rates. This could be from (1) contact with a PI animal over fence line 
boundaries, (2) a PI animal that was previously present in the group but subsequently died or 
was culled, (3) a PI animal that was only recently introduced into the group and has not yet had 
time to infect many other animals, or (4) a PI animal present in a group that is grazed 
extensively with low contact rates between animals.  If S/P is ≥ 0.75, there is high probability 
that there is currently or has very recently been at least one PI animal directly mixing with the 
group.  It is recommended that herds with high S/P ratios perform a PI hunt to identify and 
remove any potential PI animals that may be present. 
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2.5.1.3 Bulk tank milk Ab-ELISA 
Bulk tank milk (BTM) antibody-ELISA is widely used in dairy herds to assess the level of 
immunity against BVDV in the milking herd (Beaudeau, Belloc, Seegers, Assié, Pourquier, et 
al., 2001; Beaudeau, Belloc, Seegers, Assié, Sellal, et al., 2001; Eiras, Arnaiz, Sanjuán, Yus, 
& Diéguez, 2012; C. Heuer et al., 2007; S. R. Lanyon et al., 2014).  A BTM sample can be 
collected for testing at any time when there are lactating cows in the herd.  The antibody-ELISA 
results are expressed as an S/P ratio and various cut-off points are used to make inferences 
about BVDV seroprevalence in the herd (Beaudeau, Belloc, Seegers, Assié, Pourquier, et al., 
2001; Houe et al., 2006; Niskanen, 1993). For example, the cut-off points for S/P ratios in a 
New Zealand study were reported as S/P ratios <0.25 to be negative, low (0.25 < S/P ≤ 0.5), 
moderate (0.5 < S/P ≤ 0.75), high (0.75 < S/P ≤ 1.0), and very high (S/P > 1.0) (Gates, Evans, 
Heuer, et al., 2020). In general, dairy herds with bulk milk S/P ratios >0.75 are the considered 
highly likely to have at least one PI animal amongst the mixed-age cows, replacement heifers, 
or calves (G. Thobokwe, C. Heuer, & D. Hayes, 2004). .  
The main limitation of BTM Ab-ELISA is that a single test result is often difficult to interpret 
in isolation since it can take several years for antibody levels to drop in herds that have recently 
cleared BVDV infections depending on the culling and replacement rates in the milking herd 
(R. E. Booth, Cranwell, & Brownlie, 2013). Furthermore, this test is not particularly sensitive 
for detecting new BVDV incursions into replacement breeding stock that occur as the result of 
a small number of susceptible milking cows that were exposed to BVDV during the risk period 
for generating PI calves (i.e. creating a Trojan dam from transient nose-to-nose contact over 
fence lines or through contaminated trucks/equipment).  In this situation, still there is a 
potential that a PI calf can be born into the herd, but not enough animals are being infected to 
trigger a large antibody response in the BTM sample.  In addition, the presence of BVD-
vaccinated animals contributing to the bulk tank can lead to transient increases in observed 
antibody levels (Gates, Evans, Heuer, et al., 2020; Gonzalez et al., 2014; Sayers, Sayers, 
Graham, & Arkins, 2015). Some farmers may be unaware of the vaccination status of animals 
that were purchased as replacements which could lead to false positive results. Due to these 
limitations, BTM Ab-ELISA is often used to assess trends in BVDV exposure over time, but 
it is recommended to be used in conjunction with other tests such as RT-PCR of BTM or annual 
calf screening to get better information on the current herd BVD status (Evans et al., 2019; 
Houe et al., 2006; Sasha R. Lanyon, Fraser I. Hill, et al., 2014). 
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2.5.2 Identify PI animals in positive herds  
When a herd-level antibody screening test has indicated that there may be active BVDV 
transmission within the herd, the next step is to identify and remove any PI animals that may 
be present since they will continue to serve as an ongoing source of infection to other 
susceptible animals (Gates, Evans, et al., 2019). These so-called PI hunts typically involve 
collecting individual blood, tissue, and/or milk samples from all individual cattle on the 
premises and testing the samples with either ACE or PCR as appropriate for the animals. 
Although testing all individual cattle is the most reliable means of removing infected animals, 
it can be prohibitively expensive for many herds and alternative strategies have been employed 
to help reduce costs.  
Firstly, sample collection can easily be timed with routine management events such as 
disbudding or placing ear tags to make PI hunts logistically easier (Dubovi, 2013). Some 
farmers will also elect to wait until animals have been removed from the herd through routine 
culling and selection to reduce the total number of individual animals that must be tested.  In 
herds that conduct genetic parentage testing on calves, the status of the dam can be inferred 
from the status of the calf. Since PI dams will always produce PI calves, a negative test result 
for the calf means that the dam was not a PI animal. On the diagnostic laboratory side, RT-
PCR can be performed on pooled serum samples from up to 50 animals (R. L. Smith, 
Sanderson, Walz, & Givens, 2008) and ACE can be performed on pooled saline from ear notch 
samples with high sensitivity (98%) and the specificity (94%) (Cleveland, Salman, & Van 
Campen, 2006).  If the results from the pool are negative, there is no need to test the individual 
samples from the pool. It should be noted that ACE is not reliable for use pooled serum samples 
as the reported sensitivity in pools containing just two serum samples is less than 15% 
(Cleveland et al., 2006). 
In dairy herds, BTM PCR provides an inexpensive means of screening all cattle contributing 
to the tank for BVDV with a  very high diagnostic sensitivity and specificity (Munoz-Zanzi, 
Johnson, Thurmond, & Hietala, 2000). All animals in the milking herd that were not 
contributing the bulk milk tank on test date should be individually tested to make sure they are 
not PI animals (S. R. Lanyon et al., 2014). The maximum theorised herd size in which a single 
PI cow can be detected has been estimated to be as high as 5000 milking cows (Radwan et al., 
1995). There have been published case reports in which detection of PIs in herds has been 
reported to range from one PI animal in a herd of 132 to two PI cows in a herd of 800 (Sasha 
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R. Lanyon, Fraser I. Hill, et al., 2014; R. W. Renshaw, R. Ray, & E. J. Dubovi, 2000).  If the 
test result is negative, then no further testing is required. If the test result is positive, some 
farmers will use a stepwise approach for finding the PI animal where they start by individually 
testing the bottom 10 to 25% of cows in the herd based on performance and working 
sequentially upwards in deciles or quartiles until the PI animal is found and the subsequent 
BTM samples come back negative.  For dairy herds that conduct routine herd tests to measure 
milk yields, milk composition, and somatic cell counts on individual animals, a convenient 
time to perform bulk milk PCR is on one of the regularly scheduled test dates since this 
provides an accurate record of all animals contributing to the tank and individual milk samples 
are available for testing should the BTM results come back positive.  It is also important to 
remember that dairy herds with negative BTM results may still have PI animals amongst 
replacement heifers and these animals should be tested individually to prevent future incursions 
into the milking herd. 
One of the significant limitations in conducting a PI hunt is that there are currently no 
diagnostic tests that can accurately determine the BVDV status of foetuses in pregnant cattle. 
This means (1) that a herd cannot be declared BVD free until those calves have been born and 
tested for BVDV and (2) that the herd status becomes unknown as soon as there are new 
pregnant cattle in herd or if animals with an unknown BVD status are introduced into the herd. 
Another common source of frustration for farmers is when the PI hunt fails to find any PI 
animals, which is usually the result of the PI animals already having died or been culled by the 
time testing is performed. However, performing the PI hunt is still advantageous since the 
animals that test negative can be certified as being non-PI for life.  
2.6 Application of diagnostic tests to control BVDV at the industry level 
For countries with national BVDV eradication programmes, diagnostic tests have played a 
central role in facilitating efforts to reduce the prevalence of disease across the cattle industries. 
In earlier years, diagnostic tests were mainly used to confirm clinical cases of BVDV. 
However, that approach had no significant impact on lowering national BVDV prevalence 
since it was not particularly sensitive for detecting infected herds or monitoring herd re-
infection. After better characterising both the role of PI animals in BVDV transmission and the 
economic losses caused by the subsequent BVDV infections, several European countries 
capitalised on the advances in BVDV diagnostic testing to implement national and regional 
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control and/or eradication campaigns.  The first large-scale BVD eradication programmes were 
launched in the Scandinavian countries in 1990s with the goal of achieving BVD-free status 
within 10 years (Hult & Lindberg, 2005; Rikula, Nuotio, Aaltonen, & Ruoho, 2005). Following 
the success of these programmes, many other European countries have now launched BVDV 
control programs based on similar targets and using different combinations of control 
measures. These include performing initial antibody-based screening tests to classify herd 
status, follow-up tests to identify infected individuals in infected herds, continued monitoring 
to confirm infection-free status, and vaccination to protect against fetal infections. The general 
approaches used by different counties are described in the rest of this section. 
2.6.1 Approach 1 – Testing all individual cattle for BVD 
The most straightforward and efficient method for eliminating PI animals from the population 
is testing all individual cattle for BVDV. Switzerland performed mass testing of their entire 
living cattle population for BVD viral antigen within a one-year period (2008-2009) followed 
by annual calf testing to verify the status of all animals subsequently entering the population. 
However, this mass-testing approach can be prohibitively expensive and so countries like 
Ireland, Belgium, and Germany introduced legislation that required farmers to test only new-
born calves based on the assumption that older PI animals will eventually leave the population 
through death or culling. Some countries have further requirements that all cattle moved 
between locations or sold to a different farm must first be individually tested to prevent BVD 
spread through animal movements. The approach of calf testing has generally been successful 
in eliminating PI animals in part because most European counties already have legislation in 
place that requires new-born calves to have a national identification ear tag placed shortly after 
birth for traceability purposes. Using tag-and-test devices which collect an individually labelled 
ear notch sample at the same time as the ear tag is place made it easy to link the BVD test 
results to the animal’s record in national livestock traceability database. In addition, this 
approach has the advantage that herds can still use vaccination as an adjunctive control measure 
because the antibodies produced in response to vaccination do not interfere with either PCR or 
ACE performed on ear notch samples. Germany has implemented systematic vaccination in 
addition to calf testing as a part of its national BVD control programme to protect pregnant 
animals against fetal infection. Overall, this general approach of testing individual animals has 
achieved great success by reducing the PI prevalence  from 1.3% to 0.02% in Switzerland 7% 
to 0.06% in Ireland and 0.48% to 0.01% in Germany (Bachofen et al., 2013; Metcalfe, 2019).    
34 
 
2.6.2 Approach 2 – Using serological screening tests followed by PI hunts 
Although testing of all individual cattle against BVDV is the most effective way of identifying 
and removing PI animals, it can be prohibitively expensive to maintain especially as the 
prevalence of PI animals in the population declines and most tests would be expected to return 
negative results. Some countries have therefore employed a two-step approach with initial 
serological screening to determine whether there is evidence of active BVDV infections 
followed by PI hunts in herds that are classified as positive based on the antibody levels in 
tested stock.  BTM samples are often used for surveillance in dairy herds while spot tests or 
pooled serum antibody ELISA remain the tests of choice for beef herds and other dry stock (R. 
E. Booth et al., 2013). Some countries will still require that all individual cattle moved between 
locations or sold to other farms are individually tested to prevent BVD spreading through 
animal movements. The main advantage of this approach to national BVD control is that it can 
significantly reduce unnecessary testing costs by limiting individual animal testing to herds 
that are at high risk of having PI animals based on their serological results. The main limitations 
of this strategy are that vaccination cannot be used as a biosecurity measure because of its 
potential to interfere with the serological result and that  the serological test results may have 
low sensitivity in herds with recent infections and low specificity in herds with historical 
infections.  Scotland has successfully applied this two-step approach for their BVDV 
eradication programme and have removed the options of BTM testing in their national program 
relying instead on serological screening of representative unvaccinated young animals who 
have been in close contact for at least two months to address these limitations  (Metcalfe, 2019).   
2.6.3 Approach 3 – hybrid approach of screening + annual calf testing 
Some BVDV control programs use a hybrid approach that involves screening of herds to 
determine the need for a PI hunt plus annual calf testing to catch any potential breakthroughs 
in herd biosecurity. This approach efficiently controls the two main ways that PI animals can 
be introduced to the herd: the birth of PI calves from Trojan dams and purchased PI replacement 
breeding animals. Denmark has applied this combined testing approach for their BVDV 
eradication program. In early 1994, nearly 39% of dairy herds in Denmark were estimated as 
persistently infected at which point the hybrid approach was used to accelerate the removal of 
PIs from the herds. In the Denmark approach, BTM screening and spot testing have been 
performed with subsequent antigen testing of young stock (Bitsch & Rønsholt, 1995). 
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2.6.4 Ongoing monitoring  
At present, many Western European countries have already either achieved BVD-free status or 
have regional or national control programmes underway. Once disease prevalence is reduced, 
the next challenge is identifying the new cases rapidly and cost-effectively to maintain the 
disease-free status. This is particularly important since unvaccinated BVDV negative herds 
will lose natural immunity as fewer susceptible animals are getting infected by PI animals, 
which could lead to more severe consequences if a new BVDV outbreak occurs. Therefore, 
ongoing monitoring programs are important to identify incursions before they can significantly 
impact breeding cattle 
Different countries have employed different monitoring programs to ensure the BVD free 
status of their national herds. Countries like Denmark, Sweden and Norway that do not 
routinely vaccinate animals for BVDV, perform annual serological screening using either bulk 
milk tests or spot tests as the primary monitoring methods. Serological screening of BTM can 
be helpful for understanding the temporal trends of BVDV exposure over time but are less 
widely used due to the previously discussed limitations. Annual calf testing serves as both a 
monitoring and control tool to catch any potential breakthroughs (Houe et al., 2006; Metcalfe, 
2019).    
2.6.5 Use of molecular epidemiology in national control programmes 
Genetic characterization and phylogenetic analysis contribute to further clarify the 
relationships between the genetic diversity of the virus and its geographic distribution and also 
the routes of circulation of the different subtypes in a particular geographical location 
characterized by a BVDV high genetic variability (Luzzago et al., 2012). Further, it is 
important to know which subtypes of the virus are circulating and how their prevalence is 
changing over time to effectively control BVDV by vaccination (Workman et al., 2016). To 
date at least twenty-five different BVDV-1 and BVDV-2 sub-genotypes have been described 
(Yesilbag et al., 2017).  
 Phylogenetic methods have been used by different countries for their national BVDV control 
campaigns to investigate the source of the infection. Sweden was the first country to apply 
molecular epidemiology systematically in their BVDV control programme. This approach has 
sped up the final phase of their BVD-programme to reach complete eradication by facilitating 
the trace of new infections from  previously free herds where the route of transmission was not 
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clearly understood (Ståhl et al., 2005b). The United Kingdom has linked the molecular 
epidemiology with cattle movement data for the first time to elucidate potential sources and 
routes of infection of BVDV at national level (Richard E. Booth et al., 2013b). Similar methods 
have been used to investigate the molecular epidemiological characteristics of BVDV in Italy 
(Bazzucchi et al., 2017; Ebranati et al., 2018; Luzzago et al., 2012), South Korea (Choi & Song, 
2011), Canada (A. Chernick & van der Meer, 2017), Slovenia (Toplak, Barlic-Maganja, 
Hostnik, & Grom, 2002), USA (Workman et al., 2016) and China (Wang et al., 2020).  
2.7 Discussion 
Since the first BVD virus isolation in the 1960s, there have been significant advances in BVDV 
diagnostic tests that have enabled the disease to be controlled more successfully and cost-
effectively at both the herd and national levels. Several techniques for the diagnosis of BVDV 
infections have been developed recently that have allowed affordable widespread testing of 
animals for BVDV infection. In particular, the introduction of bulk milk PCR and antibody 
ELISA has provided a convenient and inexpensive means of screening large dairy herds for 
evidence of active infection and exposure, while spot tests and pooled serum antibody tests are 
useful as inexpensive alternatives for screeding non-dairy animals and beef stock. However, it 
should be noted that although these screening tests are highly sensitive in detecting herds with 
active infections, there are some issues with specificity in herds where the PI animals have 
already died or removed at the time of testing could lead false positive results.  
There have also been recent improvements with regards of testing individuals including the 
introduction of tag-and test-devices that enable samples to be collected at the same time as the 
national animal identification tag is placed, which makes it more convenient to screen the 
population for PI animals at earlier age and track the status of individual animals at a national 
level. Further, many commercial diagnostic laboratories now offer BVD testing as an optional 
add-on to routine herd milk quality testing, which can help dairy herds save on costs of 
additional sample collection. The introduction of rapid pen-side lateral flow tests have also 
been useful  for diagnosing clinical cases with compatible similar signs of mucosal disease so 
the farmers can decide whether to treat or remove the animal from the farm based on the test 
results. Farmers themselves can also use rapid tests for screening new-borns and confirming 
the BVDV status of purchased animals before bringing them into the herd.   
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Although national BVDV control programs have made significant progress through the 
successful application BVDV diagnostic tests, there are remaining limitations with the current 
BVDV diagnostic test methods to be discussed. Firstly, there are some significant limitations 
when applying screening tests in cattle populations where vaccination is used as a control 
measure and also serological tests are unreliable in animals under 10 months of the age. 
Particularly for seasonal beef herds, by the time the tests can be performed in youngstock, it is 
generally too late in the calendar year to implement control measures to stop BVDV 
transmission if the results indicate that a PI animal may have been present. Secondly, there are 
no BVDV serological tests with true DIVA (differentiating infected from vaccinated animals) 
test properties, which limits the ability for countries to use vaccination and serological tests 
together in national control programmes.  
Another limitation is that none of the available diagnostic tests can accurately determine the 
BVDV status of the fetus in pregnant cattle. This means that farmers who purchase pregnant 
replacement dams risk introducing BVDV to their herds through the birth of PI calves.  This is 
again a greater issue for beef cattle herds where calves remain with their dams until weaning 
and it can be difficult to individually test and remove PI animals before they have the 
opportunity to expose pregnant dams during the next mating period.  Finally, there are still 
remaining issues with the gold standard recommendation of waiting three to four weeks to re-
test virus positive animals to confirm their PI status.  Not only is it expensive to re-test animals, 
but the suspect animals are also potentially spreading BVDV to other cattle on farm while the 
confirmation test results are pending. With the current qRT-PCR and antigen ELISA protocols, 
it is possible to establish cut-off values above which an animal is almost certainly a PI animal 
and cut-off values below which an animal is almost certainly TI animal.  However, there 
remains a grey zone in the middle where it is impossible to distinguish low shedding PI animals 
from high-shedding TI animals.  In these situations, the options are either to re-test the animal 
in 3 to 4 weeks or immediately cull with the acknowledgement that some TI animals may be 
unnecessarily removed.   
Advances in molecular sequencing methods have also provided promising tools to improve the 
efficiency of national BVD eradication programmes by, for example,  permitting contact 
tracing through phylogenetic analysis to identify the likely sources of new BVDV introductions 
into a herd or monitoring the circulating BVDV strains to ensure that vaccines are targeted to 
provide adequate protection (Ståhl et al., 2005a). However, few countries have applied 
molecular epidemiology to their national control efforts with the most likely reason being the 
38 
 
relative expense of molecular methods as well as the need for specialised equipment. However, 
the costs of sequencing continue to decline and as the technology becomes more available in 
commercial diagnostic laboratories, there may be more opportunities to apply it widely in 
national control programmes. There is a need for establishing a BVDV sequence database with 
clear protocols for the appropriate gene(s) target for sequencing analysis.  
Overall, this literature review has highlighted that there is no one-size-fits all approach for 
applying BVDV diagnostic tests to control programmes at either the herd or national level.  
However, by integrating knowledge about test performance with an understanding of how the 
cattle industries work, it is possible to design cost-effective strategies for eliminating the 




3. Preliminary phylogenetic analysis of bovine viral diarrhoea 
virus (BVDV) subtypes across dairy farms in New Zealand 
3.1 Abstract  
Bovine viral diarrhoea virus (BVDV) is an important global viral pathogen that causes 
significant economic losses to the cattle industry. Control of BVDV in New Zealand is reliant 
on a voluntary test and cull programme.  In some countries the application of molecular 
epidemiology has assisted to trace the routes of transmission of BVDV, yet to date there is very 
little information regarding the BVDV genotypes circulating in New Zealand. Thus, this study 
was designed to provide preliminary data on the circulating BVDV subtypes in dairy farms 
across New Zealand. A convenience sample of BVDV-positive dairy serum samples (n=103) 
as determined by diagnostic laboratories during routine BVDV screening were used for the 
study. Of them, 35 samples that were positive for 5’UTR primers and 26 samples that were 
positive for Npro primers were used for the phylogenetic analysis. The phylogenetic analysis of 
5’UTR, and Npro region confirmed all the dairy isolated were belonged to BVDV-1A and 
showed 95-100% sequence homology with previously identified overseas isolates and 98-
100% sequence homology to 1A isolates recently identified in New Zealand beef cattle.  
Although unique variation among the BVDV isolates from dairy cattle was observed, some 
isolates did appear to be highly conserved (99-100%) when compared to other isolates from 
the same farm, among farms in the same region and between regions.  Therefore, with further 
molecular characterization and improved sensitivity of the assays used for phylogenetic 
analysis it may be possible to use the sequence similarities and variations as a tool in tracing 
transmission patterns in disease control programs. 
3.2 Introduction 
Bovine viral diarrhoea (BVD) is an OIE-listed cattle disease that causes significant economic 
impacts in affected herds and has been detected in more than 88 countries worldwide since 
1946 (Pinior, Garcia, Minviel, & Raboisson, 2019; Ridpath, 2010). The virus is a member of 
the genus Pestivirus, which belongs to family Flaviviridae. Pestiviruses are highly variable 
both antigenically and genetically with the genus currently containing many important species 
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including bovine viral diarrhoea virus 1 (BVDV-1), bovine viral diarrhoea virus 2 (BVDV-2), 
Border disease virus (BDV), classical swine fever virus (CSFV), and the recently added HoBi-
like pestivirus also called BVDV-3 (Anonymous, 2020; Simmonds, Becher, Bukh, Gould, 
Meyers, Monath, Muerhoff, Pletnev, Rico-Hesse, Smith, Stapleton, et al., 2017; D. B. Smith et 
al., 2016; Wang et al., 2020).  The most prevalent pestivirus species worldwide is BVDV-1 
and at least 21 sub-types have been reported at present (Wang et al., 2020; Yesilbag et al., 
2017). BVDV-1 has also been detected in diverse domestic and wildlife animal populations 
including cattle, sheep, goat, pig, deer, buffalo, bison, and alpaca (Evans, Moffat, 
Hemmatzadeh, & Cockcroft, 2017; D. B. Smith et al., 2016; Yesilbag et al., 2017).  
The BVDV genome is a positive single-stranded RNA with the length of approximately 12.3 
kb, containing a single open reading frame (ORF) flanked by two untranslated regions at the 5′ 
and 3′ end (Richard E. Booth et al., 2013b; Wang et al., 2020). The ORF encodes a polyprotein 
of approximately 4000 amino acids, that can be further cleaved into structural (C, Erns, E1, 
and E2) and non-structural (Npro, p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B) 
polypeptides (Vilček et al., 2001; Wang et al., 2020; Yesilbag et al., 2017). The BVDV-1 5′-
UTR is a non-coding region of the genome and is most commonly used for virus genotyping 
(Wang et al., 2020) because 5’ UTR contains highly conserved and variable regions which has 
allowed the development of both pan-pestivirus and species-specific RT-PCR-based diagnostic 
assays (Ridpath & Bolin, 1998; Toplak et al., 2002). Further, Npro , NS2/3 and  E2 genes are 
also being used for many assays because of  their quality of fine discrimination between closely 
related viruses (Vilček et al., 2001; Workman et al., 2016). 
Understanding the molecular epidemiology of circulating viral strains is important for disease 
control efforts to describe the genetic diversity of existing viral strains circulating through the 
population, to track virus evolution over time, and to monitor for the emergence of novel strains 
(Bazzucchi et al., 2017; Cerutti et al., 2016; A. Chernick & van der Meer, 2017; Ridpath et al., 
2011) Previous research has shown this particular importance for BVDV since the subtypes 
can shift substantially over time (Ridpath et al., 2011). The global studies have shown the 
distribution of BVDV 1 is greater than BVDV 2. The extensive genetic diversity of BVDV 
reflected by the number of detected subgenotypes has been described for several European 
countries, as well as for China and Turkey. High BVDV-1 genetic variation has been found in 
many European and Asian countries yet less genetic variation of BVDV 1 has found in the 
Americas, Australia, and Africa (Yesilbag et al., 2017). Analyses over the past two decades 
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have shown the presence of BVDV-2 in a number of European countries, including Germany, 
Belgium, France, the United Kingdom, Slovakia, and Austria (Vilcek et al., 2005).  
Many countries have used the phylogenetic analysis of virus isolates to investigate the 
molecular epidemiological characteristics of BVDV (Bazzucchi et al., 2017; A. Chernick & 
van der Meer, 2017; Choi & Song, 2011; Luzzago et al., 2012; Wang et al., 2020). The Sweden 
has applied the phylogenetic analysis to trace the unidentified routes of transmission at the 
latter part of their BVDV eradication program and that has been successful and beneficial in 
many ways to understand the epidemiological relationship between old/existing and new cases, 
to trace the chains of infection and to rule out the suspected sources of infections (Ståhl & 
Alenius, 2012; Ståhl et al., 2005b). A similar approach has been implemented within the Swiss 
eradication programme too (Stalder et al., 2016). Molecular epidemiology and evolutionary 
phylodynamics have been used in recent years for BVDV studies since the combined approach 
of traditional and molecular epidemiology has confirmed links among farms and has provided 
information useful for the eventual successful control program (Richard E. Booth et al., 2013b; 
Cerutti et al., 2016). Some studies emphasize the importance of updated knowledge regarding 
current circulating strains when producing vaccines against BVDV because the vaccines often 
only cover certain strains and there may be issues with cross-protection if there are other more 
common strains circulating in the particular geographical region (Evans et al., 2019).   
New Zealand is another country that is currently exploring eradication options because it is a 
prevalent disease with economic impacts for the country.  BVDV has become well established 
and endemic in New Zealand causing the second most impact to the dairy and beef industry 
(Reichel, Lanyon, & Hill, 2018).  The National BVD Streeting committee was established in 
2005 with the purpose of improving the knowledge of BVD among farmers and veterinarians 
(Ellison, 2011). To support this, the BVD Free Project was started on July 2017 and New 
Zealand is currently evaluating the feasibility of national eradication through the BVD free 
project. 
Several studies have been conducted to identify how the different transmission pathways 
contribute to the disease spread. Persistently infected animals (PIs)  have been identified as the 
most efficient mode of transmission of the virus under natural circumstances (C. Heuer et al., 
2007).  In addition to that, the purchase of heifers or cows, mean number and distance of 
neighbouring farms, sharing a common pasture, or over-the-fence contacts between herds have 
been shown to significantly increase the risk of BVDV transmission (J.-H. Han et al., 2018; 
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Obritzhauser, Klemens, & Josef, 2005; Valle, Martin, Tremblay, & Bateman, 1999).  These 
risk factors are highly correlated with the farm management factors  and poor farmer 
compliance with the bio security recommendations (Gates, Woolhouse, Gunn, & Humphry, 
2013). The uncertainty of contribution of different transmission pathways to disease spread 
emphasises the need of finding the most cost-effective way of limiting the transmission of 
BVDV. Molecular epidemiology is a good approach to address this problem as genetic 
characterization of isolates and phylogeographical analysis gives a unique opportunity to trace 
routes of infection  (Ebranati et al., 2018). Even though New Zealand has done many research 
studies to support BVDV control and eradication programs (Gates, Evans, Heuer, et al., 2020; 
J.-H. Han, Weston, Heuer, & Gates, 2020; C. Heuer et al., 2007)molecular epidemiological 
approach has not been included. An early study in 1998 identified a BVDV 1a genotype from 
a New Zealand cow, (Reichel et al., 2018; Vilček et al., 1998), however there is little recent 
genetic data. Further, recent studies stress the importance of studying the molecular 
epidemiology due to lack of knowledge of current circulating BVDV strains in New Zealand 
(Han J-H, 2018). Thus,  the aim of this study was to provide preliminary data on the 
characteristic distribution of currently circulating BVDV in New Zealand dairy cattle.  
3.3 Materials and Methods 
3.3.1 Sample collection  
As part of routine diagnostic screening, serum samples were collected from individual dairy 
calves by veterinarians and submitted to diagnostic laboratories throughout New Zealand. The 
blood samples were spun for 10 minutes at 3000 rpm to separate the serum.  Serum samples 
were tested for the presence of BVD viral antigens using either an Idexx BVDV antigen ELISA 
kits (Berne, Switzerland) or the Applied Biosystems™ VetMAX™ BVDV 4ALL PCR kit from 
Thermofischer Scientific (Lissieu, France). Those samples that tested positive for BVDV using 
an antigen ELISA or PCR test were submitted to Massey Veterinary School (Palmerston North) 
where they were stored at -20 °C while awaiting processing for molecular testing. 
43 
 
3.3.2 Sample processing  
3.3.2.1 RNA extraction 
Viral RNA was extracted from serum samples by means of Spin protocol of QIAGEN QIAamp 
Viral RNA Mini Kit according to the manufacturer’s instructions (QIAGEN Ltd. Hilden, 
Germany). The RNA was eluted in 60 µl of buffer and stored at -80 0C. 
3.3.2.2 RT-PCR and DNA sequencing 
The 5′-UTR and N-terminal protease (Npro) regions of the RNA genome were amplified and 
the details of the gene specific oligonucleotide primers used for the RT-PCRs are shown in the 
Table 3.1. Reverse transcription-polymerase chain reaction (RT-PCR) was performed to 
amplify the target regions of the BVDV genome by using SuperScript™ III Platinum™ One-
Step qRT-PCR Kit (Invitrogen, Waltham, MA, USA).  
Table 3.1 Details of oligonucleotide primers used for the RT-PCRs 
Gene 
Target 








Npro B31(Forward) CCATCTATRCAYACATARATGTGGT 795–771 441 bp,  
B32(Reverse) TGCTACTAAAAATCTCTGCTGT 355–376 
*The primer sequence, genomic position and predicted amplicon sizes refer to Toplak et al 
(2005). (Toplak et al., 2005) 
The 299bp region of 5’UTR was amplified using P1-U and Pest2-L primers (Toplak et al 2005) 
(Table 1). The reaction mixture for the particular RT-PCR consisted of 25 µl of 2X Reaction 
buffer, 1 unit of SuperScript™ III Platinum™ Taq enzyme mix, 0.2uM of each primer, 19µl 
of sterile distilled water and 3 µl of up to 1µg eluted RNA to a final volume of 50µl. A BVDV 
positive confirmed RNA sample was used as the positive control and distilled water was used 
as a negative control in each PCR run.  The PCR conditions were as described by Vilcek et al., 
(2001) with  an initial cDNA synthesis at 420C for 15 min, a pre-denaturation hold at 990C for 
5 min following 40 cycles of template denaturation at 940C for 45 s, primer annealing at 600C 
for 1 min and extension step at 720C for 1 min. The final 720C step was prolonged for 7 
min(Vilček et al., 2001). 
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The 441bp region of Npro of the BVDV genome was amplified using B-31 and B-32 primers 
(Toplak et al., 2005) (Table 1). The reaction mixture and the PCR conditions were same as 
described above except the initial two steps of PCR conditions where the cDNA synthesis time 
changed as 450C for 30 min, and then heat inactivation at 940C for 5 min (Grom & Barlic-
Maganja, 1999; Toplak et al., 2005).  
The 5’UTR and Npro amplicons were subjected to 1.5% (w/v) ultra-pure agarose gel 
(Invitrogen, Waltham, MA, USA) using a100bp molecular marker (Promega, Madison, USA)  
and visualized which was dyed with RedSafe (iNtRON Biotechnology, Kirkland, WA, USA) 
and inspected under a UV light, using a transilluminator, for bands that matched the expected 
sizes of the genes of interest. Positive amplicons were purified using PureLink PCR 
purification kit (Invitrogen, Waltham, MA, USA) and sent for Sanger Sequencing using the 
3130xl Genetic Analyser (Applied Biosystems Inc, California, USA) to confirm their genomic 
sequences. The electropherograms were viewed in Geneious R9 (Biomatters, Auckland, NZ) 
(Kearse et al., 2012) and checked for overlapping nucleotide peaks. Successful sequence results 
were submitted to the NCBI Blast and compared to published sequences available from 
GenBank. 
3.3.3 Phylogenetic analysis 
The sequences from our survey and reference sequences from the GenBank database including 
representatives of the Types 1A-U and Type 2 BVDV genotypes  were  trimmed to the same 
length (227  bases for UTR and 337 bases for NPRO) using GeneiousTM (Biomatters, Auckland, 
New Zealand) and aligned using Claustral W (Higgins, Thompson, & Gibson, 1994; 
Thompson, Higgins, & Gibson, 1994). A phylogenetic tree was generated in MrBayes version 
3.1   using Bayesian phylogenetics.  A general time-reversible model including invariable sites 
(GTR+I) was used.  The Bayesian phylogeny was obtained using one cold and three hot Monte 
Carlo Markov chains, which were sampled every 1000 generations over 1,500,000 generations; 
1500 trees were generated.  Of these trees, 25% were discarded as burn-in material.  The 
remaining 1125 trees were used to construct a majority consensus tree.  Bootstrap percentages 
were added to the tree at the appropriate nodes.  
The sequence divergence between and within the different lineages was calculated using a 





3.4.1 Sample collection 
Serum samples were received from both North Island and South Island. A total of 174 serum 
samples were received from 11 regions including Auckland (n = 12 from 5 farms), Otago (n= 
22 from 8 farms), Manawatu (n= 37 from 16 farms), Gisborne (n=5 from 3 farms), Waikato 
(n= 37 from 20 farms), Bay of Plenty (n= 24 from 10 farms), Northland (n= 7 from 3 farms), 
Canterbury(n = 6 from 2 farms), Hawke’s Bay (n = 4 from 4 farms) , Southland (n=7 from 3 
farms) and Wellington (n =13 from one farm). However, 42 of these samples were excluded 
because they were from beef cattle (n=7), unknown region (n=30) or samples that were broken 
or damaged in transport (n=5).  
3.4.2 RT-PCR analysis 
In general, only one to two samples from each farm were sent for genotyping and repeat 
samples were stored for later testing except for one occasion where seven samples were taken 
from a same farm to determine on-farm transmission. In total, 103 dairy serum samples were 
used for RNA extraction and subsequent RT-PCR for the detection of complimentary DNA of 
BVDV. Out of 103 RNA extractions, 48 samples were recognised by the P1-U/Pest2-L primers 
and amplified the 5’UTR products of size 299bp (Table1). Thirty-five samples that had strong 
bands of suitable intensity in gel electrophoresis sent for the sequencing.  Of the 35 samples 
that demonstrated a strong positive band for the 5’UTR, 26 samples also amplified with the 
B32/B31 Npro primers generating a PCR product of the expected size of 441 bp.  
3.4.3 Phylogenetic analysis of UTR sequences 
The geographic distribution of the samples that were successfully sequenced and used for the 
phylogenetic analysis are displayed in Figure 3.1. Of 35 samples that were sent for Sanger 
sequencing, only 31 samples were successful and were used for the phylogenetic analysis and 
representing 22 different farms in 8 regions.  
Blast analysis of the 5’UTR region revealed that the New Zealand dairy isolates were BVDV 
Type 1A and shared some sequence homology with previously identified BVDV Type 1A 
isolates from around the world, including China (range 96.9%-100%, GenBank MN417860), 
South Korea (range 96.4% - 100%, GenBank MK509773) and  Ireland (98.2%- 99.6%, 
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GenBank MW114245). Moreover, the 5’UTR region of the dairy isolates showed similarity to 
previously identified BVDV isolates from New Zealand beef cattle, such as isolates #445 and 
#603 (98.2- 100% GenBank MN961225 and MN961226). Importantly, dairy isolates # 370, 
#381, #911 and #960 showed 99.1% sequence homology with previously reported isolates from 
Korea (GenBank MK509773), China (GenBank MH490942), New Zealand pestivirus 
(AF026785) and New Zealand beef (GenBank MN961227) suggesting these isolates many be 
closely related  to each other. Similarly, dairy isolates #7-30, #6-87 and #1-27 all showed 
98.2% sequence homology with a Korean (GenBank MK509773) and a Chinese isolate 
(GenBank MH490942) but showed lower sequence homology (96.8%) with the New Zealand 
beef # 603 (MN961226) suggesting that there may be a second group of similar isolates among 
diary sequences. Further, dairy isolates #25-196, # 4-320 were 99.11% similar to a third 
Chinese isolate (GenBank MK170071), suggesting a third group. 
After BLAST analysis, the 5’UTR sequences were used for further phylogenetic analysis from 
which a phylogenetic tree was generate using BVDV Types 1A and 1C reference sequence 
(Figure 3.2). Analysis confirmed that all the New Zealand dairy sequences grouped with 
BVDV subtype 1A reference sequences. The sequence homology of 5’UTR phylogenetic 
analysis is displayed in Table 3.2.  Overall, the dairy isolates in group 1A showed 92.4%-100% 
homogeny when all the sequences where compared with each other.    Within this group, there 
appeared to be at least five distinct clusters, named from 1A-1 to 1A-5 (Figure 3.2).  Isolates 
within group 1A-1 included two samples from the same Manawatu farm which shared 99.6% 
sequence homology. Isolates within group 1A-2 included two samples from two different farms 
located in Waikato and Manawatu with 96.9% homogeny. Isolates within A1-3 showed 100% 
sequence homogeny with two samples from same farm and one sample from a different farm, 
all within the Auckland region. Isolates within A1-4 showed 98.3%-99.1% sequence 
homogeny with three different samples from three different locations in South Island. Finally, 
all the samples from A1-5 came from a same farm located in Otago that had 99.1% -100% 




Figure 3.1 Geographical distribution of 5’UTR and NPro isolates of BVDV in New Zealand 
analysed in the study 
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*Twenty-one representative BVDV isolates from New Zealand dairy cattle (bold) and previously published 
BVDV sequences representing type1A-U present in the GenBank. Names of the lineages (when available) and 
GenBank accession numbers of the sequences are given after the virus type grouping and location isolated is 
identified in within brackets. The branch lengths are drawn proportionally to the amount of changes (scale bar is 
shown). The clusters of New Zealand dairy sequences are named A1-1 to A1-5.  
  





Table 3.2 The sequence homology (in percentage) between 5 5’ UTR gene representative isolates and known BVDV types 
VDV type 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1.NZ beef HW.7 -               
2. Type 1C Australia 91.1 -              
3. 1100 (Bay of Plenty) 92.4 94.2 -             
4. 50 (Manawatu) 90.3 92.0 96.5 -            
5. NZ beef 603 98.0 93.7 99.2 97.3 -           
6. 224 (Canterbury) 91.5 93.7 99.1 96.4 99.1 -          
7. 419 (Northland) 91.5 93.2 96.9 94.7 97.3 96.9 -         
8. 197 (Manawatu) 90.2 93.6 97.8 96.0 97.8 97.8 95.6 -        
9. 275 (Manawatu) 90.7 94.1 98.3 96.5 98.3 98.3 96.0 95.6 -       
10. 173 (Waikato) 89.0 91.4 96.4 95.6 96.4 96.4 94.2 96.4 96.9 -      
11. Type A Brazil 92.4 93.4 97.3 95.5 97.3 97.3 95.5 95.9 96.7 94.6 -     
12. 30 (Auckland) 90.7 93.2 98.2 96.9 98.2 98.3 96.0 97.8 98.2 96.4 96.8 -    
13. 196 (Southland) 91.2 92.8 96.0 92.4 95.1 95.1 93.8 93.8 94.2 93.4 95.5 94.2 -   
14. 911 (Otago) 91.5 93.2 98.2 95.5 98.2 98.3 96.9 96.9 97.3 95.6 97.7 97.3 96.0 -  
15. 955 (Otago)  91.1 92.7 97.8 95.1 97.8 97.8 96.4 96.4 96.9 96.0 97.2 96.9 96.4 99.6 - 
aNumbers correspond to the numbers of BVDV Types in Figure 2 in which the phylogenetics of the BVDV isolates anf the GenBank assession numbers are given.  Sequence homogeny was 
calculated with the use of a Jakes-Cantor model of submission. The new isolates are given in bold.
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3.4.4 Phylogenetic analysis of Npro sequences  
To confirm the groupings found with the 5’UTR sequences, partial Npro gene sequences were 
analysed. Twenty-six samples showed the presence of an amplicon at the expected size (441 
bp). Upon sequencing, only nine samples had positive sequence (Table 3.4).   
 Blast analysis revealed that these nine New Zealand dairy isolates were similar to previously 
identified BVDV isolates from China (96.1 %- 98.5% GenBank MH490942 and MH417939 ), 
and South Korea (96.1% - 97.9%, GenBank JQ418633 and MK509773) as well as  previously 
identified isolates from New Zealand beef cattle, such as isolates #CH4 and #603 (96.1- 97.5%, 
GenBank MN954522 and MN954521) and an isolate from New Zealand goat (96.4%, 
GenBank U80900). Moreover, dairy isolates # 275 and  #197 showed 98.5%-98.6% sequence 
homology with previously reported isolates from China (GenBank MN417939.1) and 98.6%-
98.8% homology with New Zealand beef cattle  #603 (GenBank MN954521)suggesting that 
there may be a sub group of similar isolates among diary sequences. 
In order to perform further phylogenetic analysis, four of the nine were removed as the resulting 
sequence was too short at approximately 200 base pairs. The five remaining sequences 
represented five farms located in four regions (Canterbury, Wellington, Auckland and 
Manawatu). Phylogenetic analysis revealed that these five isolates clustered only with BVDV 
1A reference sequences (Figure 3.3), consistent with the 5’-UTR phylogenetic analysis and 
similar to previously identified BVDV type 1A isolates from a New Zealand goat isolate (range 
94.3-96.3%, GenBank U80900), and New Zealand beef subtype 1-A # 354 (92.0%-93.4%, 
GenBank MN 954523). Further, when the five sequences are compared to each other, they 
displayed a fairly high level of nucleotide homology ranging from 96.9 – 99.7% with the 
samples # 9-275 and # 10-197 from a same farm located in Manawatu showing 99.7% of 
sequence homology (Table 3.3).  
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*five representative BVDV isolates from New Zealand dairy cattle (bold) and previously published BVDV 
sequences representing type1A-U present in the GenBank. Names of the lineages (when available) and GenBank 
accession numbers of the sequences are given after the virus type grouping and location isolated is identified in 
within brackets. The branch lengths are drawn proportionally to the amount of changes (scale bar is shown). 
Figure 3.3 Phylogenetic analysis and comparison NPro sequences  
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Table 3.3 The sequence homology (in percentage) between 12 NPro gene representative isolates and known BVDV types 
BVDV type 1 2 3 4 5 6 7 8 9 10 11 12 
1. Type1CNew Zealand Deer -               
2. Type 1C NZ Beef 113 93.4 -              
3. Type 1A NZ Beef 354 82.2 80.8 -             
4. Type 1A Brazil 78.7 77.4 89.5 -            
5. Type 1A NZ Beef HW7 81.2 80.5 89.2 86.1 -           
6. 3-224 (Canterbury) 84.3 82.6 92.3 87.5 86.4 -          
7. 2-104 (Wellington 86.1 84.3 93 89.2 88.2 96.9 -         
8. NZ Goat (U80900) 84.5 82.8 92.2 87.6 86.6.2 94.9 95.3 -        
9. Type 1A NZ Beef 445 83.6 81.9 92 87.1 87.1 95.1 95.5 94.3 -       
10. 7-30 (Auckland) 85 83.3 93.4 88.9 87.8 97.2 97.6 96.3 97.2 -      
11. 9-275 (Manawatu) 85.4 82.9 93.4 89.2 87.5 96.9 97.2 96 96.9 99 -     
12. 10-197 (Manawatu) 85.7 83.3 93.7 89.5 87.8 97.2 97.6 96.3 97.2 99.3 99.7 -    
aNumbers correspond to the numbers of BVDV Types in Figure 3 in which the phylogenetics of the BVDV isolates anf the GenBank assession numbers are given.  Sequence homogeny was 
calculated with the use of a Jakes-Cantor model of submission. The new isolates are given in bold.
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Table 3.4  Summary of 5’UTR and NPRO isolates of BVDV from different locations in New 
Zealand analysed in the study 
















Otago Farm 1 15-424 PCR 1A - Pending 
 
Farm 2 370 PCR 1A ? Pending 
 
Farm 2 374 PCR 1A + Pending  
Farm 2 381 PCR 1A + Pending  
Farm 2 911 PCR 1A + Pending  
Farm 2 955 PCR 1A - Pending  
Farm 2 960 PCR 1A - Pending  
Farm 2 475 PCR 1A - Pending  
Farm 3  Black PCR + -   
Farm 4 443 PCR + ?   
Southland Farm 5 25-196 PCR 1A ? Pending  




Farm 6 3-224 PCR 1A 1A Pending Pending  
Farm 7 4-320 PCR 1A - Pending  
Farm 8 5-252 PCR 1A - Pending  
Farm 9 130 PCR + - 
 
 
Farm 10 26-106 PCR 1A + Pending  








Farm 11 16-584 PCR 1A 1A Pending  
Farm 12 12-50 PCR 1A ? Pending  
Farm 13 1 PCR + -   
Farm 14 A15864 PCR ? ?   
Farm 15 8-197 PCR 1A 1A Pending Pending  
Farm 15 9-275 PCR 1A 1A Pending Pending  
Farm 16 19(2) PCR 1A - Pending  
Farm 16 19(16) PCR 1A - Pending  







Farm 18 189 PCR + - 
 
 
Farm 19 11-574 PCR 1A ? Pending  
Farm 20 14-173 PCR 1A ? Pending  
Farm 21 18-111 PCR 1A ? Pending  
Farm 22 445 PCR + -   
Farm 23 21-85 PCR 1A + Pending  
Farm 24 739 PCR + -   
Farm 25 17-39 PCR 1A ? Pending  




Farm 27 1-27 PCR 1A ? Pending  
Farm 27 86 PCR + -   
Farm 28 7-30 PCR 1A 1A Pending Pending  
Farm 28 6-87 PCR 1A 1A Pending  
Farm 29 29 PCR + -   
Farm 29 7 PCR + -   
Bay of 
Plenty 
Farm 30 17-50 PCR + -   
Farm 31  13-1100 PCR 1A - Pending  
Farm 32 84 PCR + -   
Northland Farm 33 22-419 PCR 1A - Pending  
Farm 34 80 PCR + -   
Farm 35 18-127 PCR + -   
 
“+” indicates a positive PCR amplification but sample was not sequenced to determine BVD type 
“?” indicates a positive PCR amplification but sequencing results was too poor quality to determine BVD type 
“-” indicates unsuccessful PCR amplifications 
  
55 
3.4.5 Sensitivity of PCR vs ELISA/qPCR diagnostic lab 
Out of 103 RNA extractions, only 48 (47%) samples resulted in a positive 5’UTR products of 
size 299bp after RT-PCR amplification. In order to identify the reason for the poor 
amplification rate of <50%, five samples that were negative for our RT-PCR sent to IDEXX 
laboratories (NZ) ULC, Palmerston North for confirmation of their positive BVDV status using 
the antigen ELISA.  Results confirmed that the five samples were considered to be highly 
positive for BVDV, suggesting an issue with sensitivity and/or specificity resulting in poor test 
agreement between the diagnostic assays (qPCR and ELISA) and the  RT-PCR assay and the 
primers used in this study.  
3.5 Discussion 
The preliminary results of this study revealed that only the BVDV subtype 1A was present in 
dairy cattle across New Zealand.  These findings are constant with the 1A genotype identified 
in a study by Vilcek et al 1998 (Vilček et al., 1998) and a more recent study in beef cattle (Lal, 
2019).  To date, only BVDV 1-A and 1-C have been identified circulating in New Zealand 
cattle (Lal, 2019; Packianathan et al., 2017; Vilček et al., 2001) .  Given the presence of BVDV 
1-A throughout the country, it would appear that it could be considered an endemic genotype.  
This is in contrast to BVDV 1C which appears to be restricted to the Waikato region (Lal 2019).  
In this study, phylogenetic analyses of both the 5’UTR and NPro were examined. Even though 
all the dairy isolates studied belonged to the BVDV 1-A subtype a high degree of variation 
among the sequences within group 1-A were observed.  However, whilst unique variation 
among isolates was observed, some isolates did appear to be highly conserved when compared 
to other isolates from the same farm (5’UTR Group 1A-1), among farms in the same region 
(5’UTR Group 1A-3 and -5) and between regions (5’UTR Group 1A-2 and -4).  Therefore, it 
may be possible to use the sequence similarities and variations as a tool in tracing transmission 
patterns in disease control programs. For example, the genetic similarities of isolates from the 
same farm and different farms suggests on farm transmission and in between farm 
transmission.  The direction of transmission using animal movement is important to identify 
and eliminate the source of the infection.  Further, transmission data could be used to 
recommend biosecurity measures for individual farms that will help them target the specific 
pathways of re-introduction of BVD virus to the farm. Another use of having a good 
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understanding about the circulating BVDV strains on farms is that it may be possible to 
evaluate vaccine efficiencies as a control strategy.  
In addition, some dairy BVDV isolates showed 100% sequence homology with New Zealand 
beef BVDV isolates which may be evidence there is virus transmission among beef and dairy 
cattle.  Even though the direction of the transmission cannot be confirmed without historical 
animal movement data, the transmission could be suspected as from dairy industry into the beef 
industry since many surplus dairy calves in New Zealand are sold to the beef industry for 
fattening (Gates, 2021). About 20% of BVDV isolates in the world are recognized as  BVDV-
1A (Yesilbag et al., 2017). Therefore, it is not surprising that many of our dairy sequences 
showed genetic similarities with sequences that were originated from Korea, Brazil, UK, USA.   
In particular, some of the New Zealand dairy BVDV sequences showed high sequence 
similarity up to 100% with isolates of China. China remains one of the biggest markets of 
importing live cattle/ breeding stock from New Zealand the genetic similarities could be a result 
a of animal trading of breeding stock mixed with Trojan Dams (MPI, 2021). 
The main limitations of this study were limitations in the samplings and detection methods. 
Considering the experimental expenses, serum samples were not collected specifically for this 
study therefore the timing and the number of samples for the study was dependent with a third 
party, in this case, diagnostic laboratories undertaking routine BVDV testing. The study was 
designed as a one-year project and the samples were received during COVID-19 outbreak 
period.  This resulted in the sample size not being as large as expected and not representative 
of all the regions. An additional limitation was the analytical sensitivity and specificity of the 
RT-PCR used to amplify the viral isolate RNA for sequencing purposes. Since the performance 
of the RT-PCR has not been evaluated, it was difficult to predict the exact reason why almost 
50% of the serum samples which were recorded as BVDV antigen positive by the commercial 
diagnostic laboratories, did not amplify in the RT-PCR used for sequencing.. The literature 
shows evidence that the two main types of test which are used by the New Zealand diagnostic 
laboratories, qPCR using TaqMan hydrolysis and IDEXX antigen ELISA tests, have 100 % 
sensitivity and specificity (Bhudevi & Weinstock, 2001; Dubovi, 2013; Hill, Reichel, McCoy, 
& Tisdall, 2007; MacPherson, 2019). Therefore, a possible reason for our negative test results 
could be low sensitivity of the primers and/or reaction conditions used for the study.   It is also 
possible that the serum samples were not appropriately stored by the diagnostic laboratories 
whilst awaiting shipment to Massey University.  Ideally, serum should be stored at -700C to 
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prevent damage to temperature sensitive RNA.  Extended periods at 40C or frequent freeze-
thaw cycles could affect the viability of RNA for later analysis. 
Despite these limitations, this study remains the first to provide preliminary data on the BVDV 
genotypes circulating among New Zealand dairy cattle. It is hoped that the results of this study 
could be used to inform the use of molecular epidemiology with current BVD control strategies 




4. General Discussion 
4.1 Introduction  
This research was done with the purposes of (1) providing an overview of BVD diagnostic 
testing strategies to serve as a reference for making decisions about future BVD control 
programmes in New Zealand and (2) addressing the knowledge gaps of understanding the 
current circulating BVDV strains in New Zealand.   
In Chapter 2, the non-systematic review broadly discussed the chronological evolution of 
BVD diagnostic tests over the past 60 years and how they have been applied to assist with herd 
level and industry level BVDV control strategies around the world.  While advances in 
screening tests such as BTM testing and pooled serum antibody ELISA testing have had a 
significant impact on improving the cost-effectiveness of control programmes, there is clearly 
not a one-size-fits-all approach for their application.  There are unique challenges in New 
Zealand due to the different demographic structure of pastoral farming systems including the 
highly seasonal nature of reproduction and the widespread use of extensive grazing practices.   
For beef herds, the young stock screening tests have more limited value because by the time 
the tests can be performed on animals over 10 months of age, it is generally too late in the 
calendar year to implement control measures to stop BVDV transmission if the results indicate 
that a PI animal may have been present. To overcome this problem, routine vaccination of 
replacement heifers and cows is highly recommended  (J.-H. Han et al., 2020). In contrast, the 
dairy sector has shown progress with the widespread uptake of voluntary annual BTM 
screening tests (Gates, Evans, Heuer, et al., 2020), but without accurate information on the 
vaccination programmes used by each herd it can be difficult to interpret trends in the BTM 
antibody ELISA results.  Another challenge in New Zealand compared with European 
countries is that cattle are not required to be ear tagged until they reach 6 months of age so 
although there are good diagnostic tests to screen calves for PI animals almost immediately 
after birth, there has not been significant uptake of these tests.  Since dairy calves are handled 
more intensively after birth, there may be opportunities to push for increased calf testing to 
catch breakthroughs in biosecurity instead of needing to rely on vaccination to prevent the birth 
of PI animals.  For both herd types, testing all the purchased breeding cattle for BVD and 
double fencing to prevent nose-to-nose contact with cattle from other herds over shared fence 
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lines remain important elements of BVD control to block the major routes of BVD transmission 
(J.-H. Han et al., 2018).  The application of molecular epidemiology to assist with contact 
tracing may further aid in national BVD control in New Zealand and should be more thoroughly 
evaluated as part of future national disease control programmes if the cattle industries decide 
to progress towards a compulsory control programme. 
In Chapter 3, a preliminary phylogenetic analysis was undertaken to determine the circulating 
BVDV strains among dairy cattle in New Zealand. In this study we used both UTR and NPro 
phylogenetic analyses to understand sequence patterns. The study showed that only the BVDV-
1A genotype was circulating among the sampled dairy cattle. Since the study samples were 
non-representative of all the regions, it was difficult to conclude that BVDV1-A was the only 
circulating subtype among dairy cattle in New Zealand. Previous phylogenetic analyses have 
shown BVDV-1A among cattle in general and BVDV 1-C among beef cattle in one region of 
New Zealand (Lal, 2019; Vilček et al., 1998).  These subtypes are the second and third most 
frequently-reported genotypes in the world (Yesilbag et al., 2017) and are highly  associated 
with subtypes found in neighbouring countries (Robesova, Kovarcik, & Vilcek, 2009; Yesilbag 
et al., 2017).  For example, the phylogenetic analysis showed a fair homogeny of New Zealand 
dairy isolates with previously isolated overseas isolates that were originated from Korea, Japan, 
UK, USA and Brazil, amongst all the BVDV strains of our study have shown more than 95% 
of homogeny (100% homogeny with some sequences) with previously identified China BVDV 
isolates. A recent study shows that BVDV 1-A and 1-C are the most frequent subtypes in China 
(Chang et al., 2021).  China remains one of the biggest markets of importing live cattle breeding 
stock from New Zealand (MPI, 2021) from which unidentified Trojan dams could be a possible 
mode of transmission. Therefore, it will be very important to include a reliable screening 
approach for live imported cattle is New Zealand is to develop and maintain a BVDV-free 
status.  It is also possible that New Zealand may have very few subtypes due to the isolated 
geographical location of the country and the existing strict rules of importation of live 
production animals to the country.  
In this study, BVDV-1A was the subtype found among dairy cattle, but there was high sequence 
variation among the sequences within group 1-A. In the 5’UTR analysis, some isolates from 
the same farm appeared to be highly conserved and some had 100% sequence homology with 
isolates from different farms both within and outside of their region of origin. This finding 
suggests that there may have been a single introduction of BVD virus at one location which 
subsequently spread to other animals on both the same and other farms.  However, this was not 
the case for all isolates where other farms had evidence of multiple strains which suggests that 
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BVD may have been introduced from multiple different sources. The genetic similarities of 
isolates from the same farm and different farms suggest that disease transmission takes place 
both on farm and between farms. These sequence similarities and variations can be used as a 
tool to trace transmission routes. Further molecular tracing is useful in BVD control 
programmes for disease free herds to infer whether new outbreaks are from exposure to positive 
animals within the herd or from new introductions from outside sources, which may help herds 
establish better biosecurity recommendations to prevent re-introduction. 
In 5’UTR analysis, in particular, it was interesting to note that some dairy Isolates showed 
100% homogeny with previously identified New Zealand beef cattle isolates. Although the 
transmission directions cannot be confirmed without having historical animal movement data, 
it is more likely that the strains are spreading from the dairy industry into the beef industry 
since many surplus dairy calves in New Zealand are sold to the beef industry for fattening 
(Gates, 2021) . There may be some transmission in the reverse direction since beef bulls are 
often used in dairy breeding programmes as clean-up bulls for animals that failed to conceive 
to artificial insemination (Gates, 2021).  
4.2 Limitations  
The main limitations of this study were limitations in the samplings and detection methods. As 
there were limitations in receiving adequate number of samples to represent the entire country, 
the findings of this study could not be used to reflect the national status of existing circulating 
BVDV strains in New Zealand dairy cattle. Therefore, to expand this study into a national level 
survey, the sample number should be increased so that it represents all regions of the country. 
Overseas,  national phylogenetic surveys have been undertaken in England and China  using 
approximately 100 confirmed virus positive samples from all the regions of the country in a 
particular time frame  (Richard E. Booth et al., 2013b; Chang et al., 2021). However, this 
approach is more challenging in New Zealand due to the lack of required BVDV testing and 
restricted to only those farms already aware of potential BVDV issues and thus a biased sample.  
Ideally, to identify on-farm and inter-farms transmission in New Zealand dairy herds, an 
average of five BVDV positive animals from each farm as suggested (Gates, 2021). Another 
limitation of this study was the lack of clinical histories of the sampled animals with only the 
region where the samples were collected recorded. If the phylogenetic analysis is used as a tool 
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to trace the routes of the disease transmission, demographic and animal movement data should 
be included.  
There were also considerable limitations of the RT-PCR used for this study. The performance 
of the of the primers, reagents, analytical sensitivity and specificity of the test have not tested 
in advance were a major limitation of the testing methods. Since we have not evaluated the 
performance of the test, it was difficult to confirm the exact reason why 50% of the serum 
samples which were recorded as BVDV antigen positive by the commercial diagnostic 
laboratories, did not amplify in the RT-PCR used for sequencing. However, one possible reason 
could be low sensitivity of the primers.  There are several different primers identified in the 
literature for the amplification of the Npro and 5’UTR BVDV regions.  Future studies should 
examine these other primer sets in the reaction mix used in this study to determine if primers 
are the reason for the poor sensitivity. Another reason could be the denaturation of the samples 
if that were not appropriately stored by the diagnostic laboratories whilst awaiting shipment to 
Massey University.  It will be important for future work ensure that sample storage and 
management are optimal and consistent in order to limit potential storage related sample 
degradation. 
4.3 Future directions 
In order to make better inferences of the circulating BVDV strains across the country, this 
research should be extended into a national phylogenetic survey that includes both dairy and 
beef samples with adequate number that represents all the regions of the country.  A national 
gene bank should be established and updated to understand the strain variation patterns, new 
infections and virus evolutions that would be helpful to develop vaccines and to determine the 
vaccine efficiencies in disease control programs. Standard procedures and protocols for virus 
sequencing should be introduced so that it could minimize the inconsistencies of virus isolates 
and will be helpful to use as references in future genetic studies.  As BVDV has also been 
shown to infect a range of other ruminant species including sheep and deer, genetic typing 
could be applied in future studies to understand the transmission patterns among cattle and 
other ruminants in New Zealand.  
 
62 
5. References  
Abu Elzein, E., & AlKhalyifa, M. (2012). Studies on BVD involving establishment of sentinel 
calves and assessment of herd immunity in a large dairy farm in Saudi Arabia. Tropical 
Animal Health and Production, 44(3), 413. 10.1007/s11250-011-9912-3 
Afshar, A., Dulac, G. C., Dubuc, C., & Howard, T. H. (1991). Comparative evaluation of the 
fluorescent antibody test and microtiter immunoperoxidase assay for detection of 
bovine viral diarrhea virus from bull semen. Canadian journal of veterinary research, 
55(1), 91. 
Anonymous. (2020). Virus Taxonomy: The Classification and Nomenclature of Viruses (No. 
10). Journal of general Virology: International Committee onTaxonomy of Viruses. 
Retrieved from https://talk.ictvonline.org/ictv-reports/ictv_online_report/ 
Ayanwale, L. F., Fahrmann, J., Johnson, D. W., Anderson, R. K., & Kaneene, J. M. B. (1979). 
The optimal time to stain for noncytopathic bovine virus diarrhea field sample virus 
using indirect fluorescent antibody technique. Comparative Immunology, Microbiology 
and Infectious Diseases, 2(4), 469-476. https://doi.org/10.1016/0147-9571(79)90088-2 
Bachofen, C., Stalder, H., Vogt, H.-R., Wegmüller, M., Schweizer, M., Zanoni, R., & 
Peterhans, E. (2013). Bovine viral diarrhea (BVD): from biology to control. Berliner 
und Munchener tierarztliche Wochenschrift, 126(11-12), 452-461. 
Baker, J. C. (1995). The Clinical Manifestations of Bovine Viral Diarrhea Infection. Veterinary 
Clinics of North America: Food Animal Practice, 11(3), 425-445. 
https://doi.org/10.1016/S0749-0720(15)30460-6 
Bazzucchi, M., Bertolotti, L., Ceglie, L., Giammarioli, M., Rossi, E., Rosati, S., & De Mia, G. 
M. (2017). Complete nucleotide sequence of a novel bovine viral diarrhea virus subtype 
1 isolate from Italy. Archives of Virology: Official Journal of the Virology Division of 
the International Union of Microbiological Societies, 1. 10.1007/s00705-017-3486-y 
Beaudeau, F., Belloc, C., Seegers, H., Assié, S., Pourquier, P., & Joly, A. (2001). Informative 
Value of an Indirect Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection 
of Bovine Viral Diarrhoea Virus (BVDV) Antibodies in Milk. Journal of Veterinary 
Medicine, Series B, 48(9), 705-712. https://doi.org/10.1111/j.1439-0450.2001.00497.x 
Beaudeau, F., Belloc, C., Seegers, H., Assié, S., Sellal, E., & Joly, A. (2001). Evaluation of a 
blocking ELISA for the detection of bovine viral diarrhoea virus (BVDV) antibodies in 
serum and milk. Veterinary Microbiology, 80(4), 329-337. 
https://doi.org/10.1016/S0378-1135(01)00322-4 
Becher, P., Orlich, M., Shannon, A. D., Horner, G., Konig, M., & Thiel, H. J. (1997). 
Phylogenetic analysis of pestiviruses from domestic and wild ruminants. Journal of 
General Virology, 78, 1357-1366. 10.1099/0022-1317-78-6-1357 
Belak, S., & Ballagi-Pordany, A. (1991). Bovine viral diarrhea virus infection: rapid diagnosis 




Bhatia, S., Sood, R., Mishra, N., Pattnaik, B., & Pradhan, H. K. (2008). Development and 
evaluation of a MAb based competitive-ELISA using helicase domain of NS3 protein 
for sero-diagnosis of bovine viral diarrhea in cattle and buffaloes. Research in 
Veterinary Science, 85(1), 39-45. https://doi.org/10.1016/j.rvsc.2007.09.013 
Bhudevi, B., & Weinstock, D. (2001). Fluorogenic RT–PCR assay (TaqMan) for detection and 
classification of bovine viral diarrhea virus. Veterinary Microbiology, 83(1), 1-10. 
https://doi.org/10.1016/S0378-1135(01)00390-X 
Bitsch, V., & Rønsholt, L. (1995). Control of Bovine Viral Diarrhea Virus Infection Without 
Vaccines. Veterinary Clinics of North America: Food Animal Practice, 11(3), 627-640. 
https://doi.org/10.1016/S0749-0720(15)30471-0 
Bock, R. E., Burgess, G. W., & Douglas, I. C. (1986). Development of an enzyme linked 
immunosorbent assay (ELISA) for the detection of bovine serum antibody to bovine 
viral diarrhoea virus. Australian Veterinary Journal, 63(12), 406-408. 
https://doi.org/10.1111/j.1751-0813.1986.tb15884.x 
Bolin, S., Moennig, V., Kelso Gourley, N. E., & Ridpath, J. (1988). Monoclonal antibodies 
with neutralizing activity segregate isolates of bovine viral diarrhea virus into groups. 
Archives of Virology, 99(1), 117-123. 10.1007/BF01311029 
Bolin, S. R., & Ridpath, J. F. (1998). Prevalence of bovine viral diarrhea virus genotypes and 
antibody against those viral genotypes in fetal bovine serum. Journal of Veterinary 
Diagnostic Investigation, 10(2), 135-139. 
Booth, R. E., & Brownlie, J. (2016). Comparison of bulk milk antibody and youngstock 
serology screens for determining herd status for Bovine Viral Diarrhoea Virus. Bmc 
Veterinary Research, 12(1), 177. 10.1186/s12917-016-0797-2 
Booth, R. E., Cranwell, M. P., & Brownlie, J. (2013). Monitoring the bulk milk antibody 
response to BVDV: the effects of vaccination and herd infection status. Veterinary 
Record, 172(17), 449-449. 10.1136/vr.101195 
Booth, R. E., Thomas, C. J., El-Attar, L. M. R., Gunn, G., & Brownlie, J. (2013a). A 
phylogenetic analysis of Bovine Viral Diarrhoea Virus (BVDV) isolates from six 
different regions of the UK and links to animal movement data. In (Vol. 44). 
Booth, R. E., Thomas, C. J., El-Attar, L. M. R., Gunn, G., & Brownlie, J. (2013b). A 
phylogenetic analysis of Bovine Viral Diarrhoea Virus (BVDV) isolates from six 
different regions of the UK and links to animal movement data. Veterinary Research, 
44(1), 43. 10.1186/1297-9716-44-43 
Brinkhof, J., Zimmer, G., & Westenbrink, F. (1996). Comparative study on four enzyme-linked 
immunosorbent assays and a cocultivation assay for the detection of antigens associated 
with the bovine viral diarrhoea virus in persistently infected cattle. Veterinary 
Microbiology, 50(1–2), 1-6. http://dx.doi.org/10.1016/0378-1135(95)00201-4 
Brock, K. V. (1995). Diagnosis of Bovine Viral Diarrhea Virus Infections. Veterinary Clinics: 
Food Animal Practice, 11(3), 549-561. 10.1016/S0749-0720(15)30466-7 
Brodersen, B. W., White, A. K., & Smith, D. R. (1998). Immunohistochemical test on skin 
biopsies as a method for detection of cattle persistently infected with bovine viral 
diarrhea virus. Paper presented at the Proc. Am. Assoc. Bov. Pract. 
64 
 
Brownlie, J., Hooper, L. B., Thompson, I., & Collins, M. E. (1998). Maternal recognition of 
foetal infection with bovine virus diarrhoea virus (BVDV)—the bovine pestivirus. 
Clinical and Diagnostic Virology, 10(2), 141-150. https://doi.org/10.1016/S0928-
0197(98)00030-0 
Carlsson, U., Fredriksson, G., Alenius, S., & Kindahl, H. (1989). Bovine Virus Diarrhoea 
Virus, a Cause of Early Pregnancy Failure in the Cow. Journal of Veterinary Medicine 
Series A, 36(1‐10), 15-23. 10.1111/j.1439-0442.1989.tb00697.x 
Castro, M. D., Stoffregen, W. C., Brigman, G. P., & Hillard, K. A. (1997). A Method to Detect 
Bovine Viral Diarrhea Virus Contamination in Cell Cultures using Immunoperoxidase 
Staining. Journal of Veterinary Diagnostic Investigation, 9(4), 427-431. 
10.1177/104063879700900417 
Cerutti, F., Luzzago, C., Lauzi, S., Ebranati, E., Caruso, C., Masoero, L., . . . Peletto, S. (2016). 
Phylogeography, phylodynamics and transmission chains of bovine viral diarrhea virus 
subtype 1f in Northern Italy. Infection, Genetics and Evolution, 45, 262-267. 
https://doi.org/10.1016/j.meegid.2016.09.007 
Chang, L., Qi, Y., Liu, D., Du, Q., Zhao, X., & Tong, D. (2021). Molecular detection and 
genotyping of bovine viral diarrhea virus in Western China. Bmc Veterinary Research, 
17(1), 66. 10.1186/s12917-021-02747-7 
Chernick, A., Godson, D. L., & van der Meer, F. (2014). Metadata beyond the sequence enables 
the phylodynamic inference of bovine viral diarrhea virus type 1a isolates from Western 
Canada. Infection, Genetics and Evolution, 28, 367-374. 
Chernick, A., & van der Meer, F. (2017). Evolution of Bovine viral diarrhea virus in Canada 
from 1997 to 2013. Virology, 509, 232-238. 10.1016/j.virol.2017.06.024 
Choi, K. S., & Song, M. C. (2011). Epidemiological observations of bovine viral diarrhea virus 
in Korean indigenous calves. Virus Genes, 42(1), 64-70. 10.1007/s11262-010-0542-z 
Cleveland, S. M., Salman, M. D., & Van Campen, H. (2006). Assessment of a Bovine Viral 
Diarrhea Virus Antigen Capture ELISA and a Microtiter Virus Isolation ELISA Using 
Pooled Ear Notch and Serum Samples. Journal of Veterinary Diagnostic Investigation, 
18(4), 395-398. 10.1177/104063870601800414 
Collett, M. S. (1992). Molecular genetics of pestiviruses. Comparative Immunology, 
Microbiology and Infectious Diseases, 15(3), 145-154. https://doi.org/10.1016/0147-
9571(92)90087-8 
Corapi, W. V., Elliott, R. D., French, T. W., Arthur, D. G., Bezek, D. M., & Dubovi, E. J. 
(1990). Thrombocytopenia and hemorrhages in veal calves infected with bovine viral 
diarrhea virus. Journal of the American Veterinary Medical Association, 196(4), 590-
596. 
Coria, M., McClurkin, A., Cutlip, R., & Ritchie, A. (1975). Isolation and characterization of 
bovine adenovirus type 5 associated with “weak calf syndrome”. Archives of Virology, 
47(4), 309-317. 
Cornish, T. E., van Olphen, A. L., Cavender, J. L., Edwards, J. M., Jaeger, P. T., Vieyra, L. L., 
. . . O'Toole, D. (2005). Comparison of Ear Notch Immunohistochemistry, Ear Notch 
Antigen-Capture ELISA, and Buffy Coat Virus Isolation for Detection of Calves 
65 
 
Persistently Infected with Bovine Viral Diarrhea Virus. Journal of Veterinary 
Diagnostic Investigation, 17(2), 110-117. 10.1177/104063870501700203 
Cuttance, W. G., & Cuttance, E. L. (2014). Analysis of individual farm investigations into 
bovine viral diarrhoea in beef herds in the North Island of New Zealand. New Zealand 
Veterinary Journal, 62(6), 338-342. 10.1080/00480169.2014.928925 
Dekker, A., Wensvoort, G., & Terpstra, C. (1995). Six antigenic groups within the genus 
pestivirus as identified by cross neutralization assays. Veterinary Microbiology, 47(3), 
317-329. https://doi.org/10.1016/0378-1135(95)00116-6 
Deregt, D., & Prins, S. (1998). A monoclonal antibody-based immunoperoxidase monolayer 
(micro-isolation) assay for detection of type 1 and type 2 bovine viral diarrhea viruses. 
Canadian journal of veterinary research, 62(2), 152. 
Donis, R. O., Corapi, W., & Dubovi, E. J. (1988). Neutralizing Monoclonal Antibodies to 
Bovine Viral Diarrhoea Virus Bind to the 56K to 58K Glycoprotein. Journal of General 
Virology, 69(1), 77-86. https://doi.org/10.1099/0022-1317-69-1-77 
Drew, T. W., Yapp, F., & Paton, D. J. (1999). The detection of bovine viral diarrhoea virus in 
bulk milk samples by the use of a single-tube RT-PCR. Veterinary Microbiology, 64(2), 
145-154. https://doi.org/10.1016/S0378-1135(98)00266-1 
Dubovi, E. J. (2013). Laboratory diagnosis of bovine viral diarrhea virus. Biologicals, 41(1), 
8-13. https://doi.org/10.1016/j.biologicals.2012.06.004 
Ebranati, E., Lauzi, S., Cerutti, F., Caruso, C., Masoero, L., Moreno, A., . . . Luzzago, C. 
(2018). Highlighting priority areas for bovine viral diarrhea control in Italy: A 
phylogeographic approach. Infection Genetics and Evolution, 58, 258-268. 
10.1016/j.meegid.2018.01.006 
Edwards, S., Moennig, V., & Wensvoort, G. (1991). The development of an international 
reference panel of monoclonal antibodies for the differentiation of hog cholera virus 
from other pestiviruses. Veterinary Microbiology, 29(2), 101-108. 
https://doi.org/10.1016/0378-1135(91)90118-Y 
Edwards, S., Sands, J., & Harkness, J. (1988). The application of monoclonal antibody panels 
to characterize pestivirus isolates from ruminants in Great Britain. Archives of Virology, 
102(3-4), 197-206. 
Eiras, C., Arnaiz, I., Sanjuán, M. L., Yus, E., & Diéguez, F. J. (2012). Bovine viral diarrhea 
virus: Correlation between herd seroprevalence and bulk tank milk antibody levels 
using 4 commercial immunoassays. Journal of Veterinary Diagnostic Investigation, 
24(3), 549-553. 10.1177/1040638712440984 
Ellis, J., West, K., Cortese, V., Konoby, C., & Weigel, D. (2001). Effect of maternal antibodies 
on induction and persistence of vaccine-induced immune responses against bovine viral 
diarrhea virus type II in young calves. Journal of the American Veterinary Medical 
Association, 219(3), 351-356. 10.2460/javma.2001.219.351 
Ellis, J. A., Martin, K., Robert, N. G., & Haines, D. M. (1995). Comparison of Detection 
Methods for Bovine Viral Diarrhea Virus in Bovine Abortions and Neonatal Death. 




Ellison, R. S. (2011). Bovine viral diarrhoea (BVD): A framework for control in dairy and beef 
herds (Vol. Annual Seminar 2011, Volume): The society of Sheep and Beef Cattle 
Veterinarians of the New Zealand Veterinary Association. 
Evans, C. A., Moffat, J. L., Hemmatzadeh, F., & Cockcroft, P. D. (2017). The risk of 
transmission from sheep experimentally infected with BVDV-1c during the acute phase 
to BVDV naïve sheep. Small Ruminant Research, 153, 5-8. 
https://doi.org/10.1016/j.smallrumres.2017.04.022 
Evans, C. A., Pinior, B., Larska, M., Graham, D., Schweizer, M., Guidarini, C., . . . Gates, M. 
C. (2019). Global knowledge gaps in the prevention and control of bovine viral 
diarrhoea (BVD) virus. Transboundary and Emerging Diseases, 66(2), 640-652. 
10.1111/tbed.13068 
Fastier, L. B., & Hansen, N. F. (1966). The occurrence of antibodies to bovine virus diarrhoea, 
infectious bovine rhinotracheitis and parainfluenza 3 viruses in sera from New Zealand 
cattle. New Zealand Veterinary Journal, 14(3-4), 27-32. 
10.1080/00480169.1966.33629 
Fernelius, A. (1969). Characterization of bovine viral diarrhea viruses. Archiv für die gesamte 
Virusforschung, 27(1), 1-12. 
Fernelius, A. L. (1964). Noncytopathogenic bovine viral diarrhea viruses detected and titrated 
by immunofluorescence. Canadian Journal of Comparative Medicine and Veterinary 
Science, 28(5), 121. 
Fernelius, A. L., & Packer, R. A. (1969). Serological Reactions of Bovine Diarrhoea Viruses 
with Anticellular and Antivirus Sera Produced in Rabbits. Journal of General Virology, 
5(2), 243-249. https://doi.org/10.1099/0022-1317-5-2-243 
Fulton, R. W., Briggs, R. E., Payton, M. E., Confer, A. W., Saliki, J. T., Ridpath, J. F., . . . 
Duff, G. C. (2004). Maternally derived humoral immunity to bovine viral diarrhea virus 
(BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine 
respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef 
calves, antibody decline by half-life studies and effect on response to vaccination. 
Vaccine, 22(5), 643-649. https://doi.org/10.1016/j.vaccine.2003.08.033 
Fulton, R. W., Saliki, J. T., Burge, L. J., d'Offay, J. M., Bolin, S. R., Maes, R. K., . . . Frey, M. 
L. (1997). Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: 
detection by inhibition of viral cytopathology and infectivity by immunoperoxidase 
assay. Clinical and Diagnostic Laboratory Immunology, 4(3), 380-383. 
Gamlen, T., Richards, K. H., Mankouri, J., Hudson, L., McCauley, J., Harris, M., & 
Macdonald, A. (2010). Expression of the NS3 protease of cytopathogenic bovine viral 
diarrhea virus results in the induction of apoptosis but does not block activation of the 
beta interferon promoter. Journal of General Virology, 91(1), 133-144. 
https://doi.org/10.1099/vir.0.016170-0 
Gates, M. C. (2021). [Sample numbers to determine BVDV transmission]. 
Gates, M. C., Evans, C. A., Han, J. H., Heuer, C., & Weston, J. F. (2020). Practices and 
opinions of New Zealand beef cattle farmers towards bovine viral diarrhoea control in 
relation to real and perceived herd serological status. New Zealand Veterinary Journal, 
68(2), 92-100. 10.1080/00480169.2019.1692735 
67 
 
Gates, M. C., Evans, C. A., Heuer, C., Voges, H., & Weston, J. F. (2020). Temporal trends in 
bulk tank milk antibody ELISA and PCR test results for bovine viral diarrhoea in New 
Zealand pastoral dairy herds. New Zealand Veterinary Journal, 1-10. 
10.1080/00480169.2020.1806756 
Gates, M. C., Evans, C. A., Weir, A. M., Heuer, C., & Weston, J. F. (2019). Recommendations 
for the testing and control of bovine viral diarrhoea in New Zealand pastoral cattle 
production systems. New Zealand Veterinary Journal, 67(5), 219-227. 
10.1080/00480169.2019.1618745 
Gates, M. C., Han, J. H., Evans, C. A., Weston, J. F., & Heuer, C. (2019). Assessing the use of 
diagnostic laboratory accession data to support national bovine viral diarrhoea control 
in New Zealand. New Zealand Veterinary Journal, 67(4), 194-202. 
10.1080/00480169.2019.1608329 
Gates, M. C., Woolhouse, M. E. J., Gunn, G. J., & Humphry, R. W. (2013). Relative 
associations of cattle movements, local spread, and biosecurity with bovine viral 
diarrhoea virus (BVDV) seropositivity in beef and dairy herds. Preventive Veterinary 
Medicine, 112(3), 285-295. https://doi.org/10.1016/j.prevetmed.2013.07.017 
Gillespie, J. H., Coggins, L., Thompson, J., & Baker, J. A. (1961). Comparison by 
neutralization tests of strains of virus isolated from virus diarrhea and mucosal disease. 
Cornell Vet, 51, 155-159. 
Gómez-Romero, N., Basurto-Alcántara, F. J., Verdugo-Rodríguez, A., Bauermann, F. V., & 
Ridpath, J. F. (2017). Genetic diversity of bovine viral diarrhea virus in cattle from 
Mexico. Journal Of Veterinary Diagnostic Investigation: Official Publication Of The 
American Association Of Veterinary Laboratory Diagnosticians, Inc, 29(3), 362-365. 
10.1177/1040638717690187 
Gonzalez, A. M., Arnaiz, I., Eiras, C., Camino, F., Sanjuán, M. L., Yus, E., & Diéguez, F. J. 
(2014). Monitoring the bulk milk antibody response to bovine viral diarrhea in dairy 
herds vaccinated with inactivated vaccines. Journal of Dairy Science, 97(6), 3684-
3688. https://doi.org/10.3168/jds.2013-7851 
Goyal, S. M., & Ridpath, J. F. (2005). Bovine viral diarrhea virus. [electronic resource] : 
diagnosis, management, and control (1st ed ed.): Blackwell. 
Griebel, P. J. (2015). BVDV vaccination in North America: risks versus benefits. Animal 
Health Research Reviews, 16(1), 27-32. 10.1017/S1466252315000080 
Grom, J., & Barlic-Maganja, D. (1999). Bovine viral diarrhoea (BVD) infections – control and 
eradication programme in breeding herds in Slovenia. Veterinary Microbiology, 64(2), 
259-264. https://doi.org/10.1016/S0378-1135(98)00276-4 
Grooms, D. L., & Keilen, E. D. (2002). Screening of Neonatal Calves for Persistent Infection 
with Bovine Viral Diarrhea Virus by Immunohistochemistry on Skin Biopsy Samples. 
Clinical and Diagnostic Laboratory Immunology, 9(4), 898-900. 10.1128/cdli.9.4.898-
900.2002 
Hamel, A. L., Wasylyshen, M. D., & Nayar, G. (1995). Rapid detection of bovine viral diarrhea 
virus by using RNA extracted directly from assorted specimens and a one-tube reverse 
transcription PCR assay. Journal of Clinical Microbiology, 33(2), 287-291. 
68 
 
Hamers, C., Lecomte, C., Kulcsar, G., Lambot, M., & Pastoret, P. P. (1998). Persistently 
infected cattle stabilise bovine viral diarrhea virus leading to herd specific strains. 
Veterinary Microbiology, 61(3), 177-182. https://doi.org/10.1016/S0378-
1135(98)00185-0 
Han, J.-H., Holter, J., Moffat, J., Weston, J. F., Heuer, C., & Gates, M. C. (2018). Using 
Bayesian network modelling to untangle farm management risk factors for bovine viral 
diarrhoea virus infection. Preventive Veterinary Medicine, 161, 75-82. 
https://doi.org/10.1016/j.prevetmed.2018.10.014 
Han J-H, W. A. M. W. J. F. H. C. G. M. C. (2018). Elimination of bovine viral diarrhoea virus 
in New Zealand: a review of research progress and future directions. New Zealand 
Veterinary Journal, 66(6), 273-280. 10.1080/00480169.2018.1509030 
Han, J.-H., Weston, J. F., Heuer, C., & Gates, M. C. (2020). Modelling the economics of bovine 
viral diarrhoea virus control in pastoral dairy and beef cattle herds. Preventive 
Veterinary Medicine, 182, 105092. https://doi.org/10.1016/j.prevetmed.2020.105092 
Han, J. H., Weir, A. M., Weston, J. F., Heuer, C., & Gates, M. C. (2018). Elimination of bovine 
viral diarrhoea virus in New Zealand: a review of research progress and future 
directions. New Zealand Veterinary Journal, 66(6), 273-280. 
10.1080/00480169.2018.1509030 
Heuer, C., Healy, A., & Zerbini, C. (2007). Economic effects of exposure to bovine viral 
diarrhea virus on dairy herds in New Zealand. Journal of Dairy Science, 90(12), 5428-
5438. 10.3168/jds.2007-0258 
Heuer, C., Tattersfield, G., West, D., & Olson, W. (2008). Effect of reproductive pathogens on 
pregnancy rates in beef herds (Neospora caninum, BVD virus and Leptospira sv. Hardjo 
and Pomona). Proc Soc Sheep Beef Cattle Vet NZ Vet Assoc Annu Semin, 2008, 141-
147. 
Higgins, D. G., Thompson, J. D., & Gibson, T. J. (1994). ClustalW: improving the sensitivity 
of progressive multiple sequence alignment through sequence weighting, position-
specific gap penalties, and weight matrix choice. Nucleic Acids Research, 22, 4673-
4680. 
Hill, F. I., Reichel, M. P., McCoy, R. J., & Tisdall, D. J. (2007). Evaluation of two commercial 
enzyme-linked immunosorbent assays for detection of bovine viral diarrhoea virus in 
serum and skin biopsies of cattle. New Zealand Veterinary Journal, 55(1), 45-48. 
10.1080/00480169.2007.36734 
Houe, H. (1994). Bovine virus diarrhoea virus: detection of Danish dairy herds with 
persistently infected animals by means of a screening test of ten young stock. 
Preventive Veterinary Medicine, 19(3), 241-248. https://doi.org/10.1016/0167-
5877(94)90092-2 
Houe, H. (1999a). Epidemiological features and economical importance of bovine virus 
diarrhoea virus (BVDV) infections. Veterinary Microbiology, 64(2), 89-107. 
https://doi.org/10.1016/S0378-1135(98)00262-4 
Houe, H. (1999b). Epidemiological features and economical importance of bovine virus 
diarrhoea virus (BVDV) infections. Veterinary Microbiology, 64(2-3), 89-107. 
69 
 
Houe, H., Lindberg, A., & Moennig, V. (2006). Test strategies in bovine viral diarrhea virus 
control and eradication campaigns in Europe. Journal of Veterinary Diagnostic 
Investigation, 18(5), 427 - 436. 
Howard, C. J., Clarke, M. C., & Brownlie, J. (1985). An Enzyme-Linked Immunosorbent 
Assay (ELISA) for the detection of antibodies to Bovine Viral Diarrhoea Virus 
(BVDV) in cattle sera. Veterinary Microbiology, 10(4), 359-369. 
https://doi.org/10.1016/0378-1135(85)90006-9 
Hult, L., & Lindberg, A. (2005). Experiences from BVDV control in Sweden. Preventive 
Veterinary Medicine, 72(1-2), 143-148. 
Humphry, R. W., Reeves, A., & Gunn, G. J. (2018). Strategies for screening young stock for 
antibodies – optimising numbers to test, cut-points, & predictive values for bovine viral 
diarrhoea virus. Scientific Reports, 8(1), 9532. 10.1038/s41598-018-27870-8 
Jia, Y. (2012). In P. M. Conn (Ed.), Methods in Cell Biology (Vol. 112, pp. 55-68): Academic 
Press. https://doi.org/10.1016/B978-0-12-405914-6.00003-2 
Juntti, N., Larsson, B., & Fossum, C. (1987). The Use of Monoclonal Antibodies in Enzyme 
Linked Immunosorbent Assays for Detection of Antibodies to Bovine Viral Diarrhoea 
Virus. Journal of Veterinary Medicine, Series B, 34(1‐10), 356-363. 
https://doi.org/10.1111/j.1439-0450.1987.tb00408.x 
Kearse, M., Moir, R., Wilson, A., Stones-Havas, S., Cheung, M., Sturrock, S., . . . Drummond, 
A. (2012). Geneious Basic: An integrated and extendable desktop software platform for 
the organization and analysis of sequence data. Bioinformatics, 28(12), 1647-1649. 
10.1093/bioinformatics/bts199 
Kendrick, J. W., & Franti, C. E. (1974). Bovine viral diarrhea: decay of colostrum-conferred 
antibody in the calf. American journal of veterinary research, 589 - 591. 
Khodakaram-Tafti, A., & Farjanikish, G. (2017). Persistent bovine viral diarrhea virus 
(BVDV) infection in cattle herds. In (Vol. 18, pp. 154-163). 
Kuhne, S., Schroeder, C., Holmquist, G., Wolf, G., Horner, S., Brem, G., & Ballagi, A. (2005). 
Detection of Bovine Viral Diarrhoea Virus Infected Cattle – Testing Tissue Samples 
Derived from Ear Tagging Using an Erns Capture ELISA. Journal of Veterinary 
Medicine, Series B, 52(6), 272-277. 10.1111/j.1439-0450.2005.00861.x 
Lal, R. (2019). Genetic Characterisation and Rapid Detection of Bovine Viral Diarrhoea Virus 
Circulating in New Zealand Beef Herds. (Partial fulfilment of Masters in Medical 
Laboratory Sciences), Massey University,  
Lanyon, S. R., Anderson, M. L., & Reichel, M. P. (2014). Pooling serum to identify cohorts of 
nonmilking cattle likely to be infected with Bovine viral diarrhea virus by testing for 
specific antibodies. Journal of Veterinary Diagnostic Investigation, 26(3), 346-353. 
10.1177/1040638714526596 
Lanyon, S. R., Hill, F. I., Reichel, M. P., & Brownlie, J. (2014). Bovine viral diarrhoea: 
Pathogenesis and diagnosis. The Veterinary Journal, 199(2), 201-209. 
https://doi.org/10.1016/j.tvjl.2013.07.024 
Lanyon, S. R., McCoy, R., Bergman, E., & Reichel, M. P. (2014). Milk as a diagnostic sample 
for a commercially available ELISA to identify bovine viral diarrhoea (BVD) 
70 
 
antibodies in dairy herds. Australian Veterinary Journal, 92(7), 269-273. 
10.1111/avj.12188 
Lanyon, S. R., & Reichel, M. P. (2014). Bovine viral diarrhoea virus ('pestivirus') in Australia: 
to control or not to control? In (Vol. 92, pp. 277-282). 
Laureyns, J., Ribbens, S., & de Kruif, A. (2010). Control of bovine virus diarrhoea at the herd 
level: Reducing the risk of false negatives in the detection of persistently infected cattle. 
The Veterinary Journal, 184(1), 21-26. 
Lindberg, A. L. E., & Alenius, S. (1999). Principles for eradication of bovine viral diarrhoea 
virus (BVDV) infections in cattle populations. Veterinary Microbiology, 64(2-3), 197-
222. 
Lopez, O. J., Osorio, F. A., & Donis, R. O. (1991). Rapid detection of bovine viral diarrhea 
virus by polymerase chain reaction. Journal of Clinical Microbiology, 29(3), 578-582. 
Ludemann, L. R., & Katz, J. B. (1994). Enzyme-linked Immunosorbent Assay Assessment of 
Bovine Viral Diarrhea Virus Antigen in Inactivated Vaccines using Polyclonal or 
Monoclonal Antibodies. Biologicals, 22(1), 21-27. 
https://doi.org/10.1006/biol.1994.1004 
Luzzago, C., Ebranati, E., Sassera, D., Lo Presti, A., Lauzi, S., Gabanelli, E., . . . Zehender, G. 
(2012). Spatial and temporal reconstruction of bovine viral diarrhea virus genotype 1 
dispersion in Italy. Infection Genetics and Evolution, 12(2), 324-331. 
10.1016/j.meegid.2011.12.007 
MacPherson, A. T. (2019). Calf age does not affect test sensitivity or specificity for detection 
of bvd using idexx antigen-elisa on ear notch tissue, . 
Magar, R., Minocha, H., Montpetit, C., Carman, P., & Lecomte, J. (1988). Typing of cytopathic 
and noncytopathic bovine viral diarrhea virus reference and Canadian field strains using 
a neutralizing monoclonal antibody. Canadian journal of veterinary research, 52(1), 
42. 
Maisonnave, J., & Rossi, C. (1982). A microtiter test for detecting and titrating 
noncytopathogenic bovine viral diarrhea virus. Archives of Virology, 72(4), 279-287. 
Metcalfe, L. (2019). An Update on the Status of BVD Control and Eradication in Europe 
Veterinary Science & Medicine. Journal of Veterinary Medical Science, 7 
Meyers, G., & Thiel, H.-J. (1996). In K. Maramorosch, F. A. Murphy, & A. J. Shatkin (Eds.), 
Advances in Virus Research (Vol. 47, pp. 53-118): Academic Press. 
https://doi.org/10.1016/S0065-3527(08)60734-4 
Meyling, A. (1984). Detection of BVD Virus in Viremic Cattle by an Indirect 
Immunoperoxidase Technique. In M. S. McNulty & J. B. McFerran (Eds.), Recent 
Advances in Virus Diagnosis: A Seminar in the CEC Programme of Coordination of 
Research on Animal Pathology, held at the Veterinary Research Laboratories, Belfast, 
Northern Ireland, September 22–23, 1983 (pp. 37-46). Dordrecht: Springer 
Netherlands. 10.1007/978-94-009-6039-8_4 
Meyling, A., Houe, H., & Jensen, A. (1990). Epidemiology of bovine virus diarrhoea virus. 
Rev Sci Tech, 9(1), 75-93. 
71 
 
Mignon, B., Waxweiler, S., Thiry, E., Boulanger, D., Dubuisson, J., & Pastoret, P. P. (1992). 
Epidemiological evaluation of a monoclonal ELISA detecting bovine viral diarrhoea 
pestivirus antigens in field blood samples of persistently infected cattle. Journal of 
Virological Methods, 40(1), 85-93. https://doi.org/10.1016/0166-0934(92)90010-B 
Moennig, V., & Liess, B. (1995). Pathogenesis of Intrauterine Infections With Bovine Viral 
Diarrhea Virus. Veterinary Clinics of North America: Food Animal Practice, 11(3), 
477-487. https://doi.org/10.1016/S0749-0720(15)30462-X 




Munoz-Zanzi, C. A., Johnson, W. O., Thurmond, M. C., & Hietala, S. K. (2000). Pooled-
sample testing as a herd-screening tool for detection of bovine viral diarrhea virus 
persistently infected cattle. Journal of Veterinary Diagnostic Investigation, 12(3), 195-
203. 10.1177/104063870001200301 
Muñoz-Zanzi, C. A., Thurmond, M. C., Johnson, W. O., & Hietala, S. K. (2002). Predicted 
ages of dairy calves when colostrum-derived bovine viral diarrhea virus antibodies 
would no longer offer protection against disease or interfere with vaccination. J Am Vet 
Med Assoc, 221(5), 678-685. 10.2460/javma.2002.221.678 
Nettleton, P. F., & Entrican, G. (1995). Ruminant pestiviruses. British Veterinary Journal, 
151(6), 615-642. https://doi.org/10.1016/S0007-1935(95)80145-6 
Neufeldt, C. J., Cortese, M., Acosta, E. G., & Bartenschlager, R. (2018). Rewiring cellular 
networks by members of the Flaviviridae family. Nature Reviews. Microbiology, 16(3), 
125-142. 10.1038/nrmicro.2017.170 
Niskanen, R. (1993). Relationship between the levels of antibodies to bovine viral diarrhoea 
virus in bulk tank milk and the prevalence of cows exposed to the virus. The Veterinary 
Record, 133(14), 341-344. 
Njaa, B. L., Clark, E. G., Janzen, E., Ellis, J. A., & Haines, D. M. (2000). Diagnosis of 
Persistent Bovine Viral Diarrhea Virus Infection by Immunohistochemical Staining of 
Formalin-Fixed Skin Biopsy Specimens. Journal of Veterinary Diagnostic 
Investigation, 12(5), 393-399. 10.1177/104063870001200501 
Obritzhauser, W., Klemens, F., & Josef, K. (2005). BVDV infection risk in the course of the 
voluntary BVDV eradication program in Styria/Austria. Preventive Veterinary 
Medicine, 72(1-2), 127-132. 
Ohmann, H. B. (1983). Pathogenesis of bovine viral diarrhoea-mucosal disease: distribution 
and significance of BVDV antigen in diseased calves. Research in Veterinary Science, 
34(1), 5-10. 
OIE. (2021). OIE-Listed diseases, infections and infestations 
in force in 2021. Retrieved 2021 from https://www.oie.int/animal-health-in-the-world/oie-
listed-diseases-2021/ 
Packianathan, R., Clough, W. J., Hodge, A., Holz, D. K., Huang, J., Bryant, G. L., & Colantoni, 
C. (2017). Prevention of fetal infection in heifers challenged with bovine viral diarrhoea 
72 
 
virus type 1a by vaccination with a type 1c or type 1a vaccine. New Zealand Veterinary 
Journal, 65(3), 134-139. 10.1080/00480169.2017.1291376 
Paton, D. J., Ibata, G., Edwards, S., & Wensvoort, G. (1991). An ELISA detecting antibody to 
conserved pestivirus epitopes. Journal of Virological Methods, 31(2), 315-324. 
https://doi.org/10.1016/0166-0934(91)90169-Z 
Peters, W., Greiser-Wilke, I., Moennig, V., & Liess, B. (1986). Preliminary serological 
characterization of bovine viral diarrhoea virus strains using monoclonal antibodies. 
Veterinary Microbiology, 12(3), 195-200. https://doi.org/10.1016/0378-
1135(86)90048-9 
Pinior, B., Firth, C. L., Richter, V., Lebl, K., Trauffler, M., Dzieciol, M., . . . Kasbohrer, A. 
(2017). A systematic review of financial and economic assessments of bovine viral 
diarrhea virus (BVDV) prevention and mitigation activities worldwide. Preventive 
Veterinary Medicine, 137, 77-92. 10.1016/j.prevetmed.2016.12.014 
Pinior, B., Garcia, S., Minviel, J. J., & Raboisson, D. (2019). Epidemiological factors and 
mitigation measures influencing production losses in cattle due to bovine viral 
diarrhoea virus infection: A meta-analysis. Transboundary and Emerging Diseases, 
66(6), 2426-2439. 10.1111/tbed.13300 
Potgieter, L. N. D. (1995). Immunology of Bovine Viral Diarrhea Virus. Veterinary Clinics of 
North America: Food Animal Practice, 11(3), 501-520. https://doi.org/10.1016/S0749-
0720(15)30464-3 
Radwan, G. S., Brock, K. V., Hogan, J. S., & Smith, K. L. (1995). Development of a PCR 
amplification assay as a screening test using bulk milk samples for identifying dairy 
herds infected with bovine viral diarrhea virus. Veterinary Microbiology, 44(1), 77-91. 
Reichel, M. P., Lanyon, S. R., & Hill, F. I. (2018). Perspectives on Current Challenges and 
Opportunities for Bovine Viral Diarrhoea Virus Eradication in Australia and New 
Zealand. In (Vol. 7). 
Renshaw, R., Ray, R., & Dubovi, E. (2000). Comparison of virus isolation and reverse 
transcription polymerase chain reaction assay for detection of bovine viral diarrhea 
virus in bulk milk tank samples. Journal of Veterinary Diagnostic Investigation, 12(2), 
184-186. 
Renshaw, R. W., Ray, R., & Dubovi, E. J. (2000). Comparison of Virus Isolation and Reverse 
Transcription Polymerase Chain Reaction Assay for Detection of Bovine Viral 
Diarrhea Virus in Bulk Milk Tank Samples. Journal of Veterinary Diagnostic 
Investigation, 12(2), 184-186. 10.1177/104063870001200219 
Richter, V., Kattwinkel, E., Firth, C. L., Marschik, T., Dangelmaier, M., Trauffler, M., . . . 
Baumgartner, W. (2019). Mapping the global prevalence of bovine viral diarrhoea virus 
infection and its associated mitigation programmes. Veterinary Record, 184(23), 711. 
10.1136/vr.105354 
Richter, V., Lebl, K., Baumgartner, W., Obritzhauser, W., Kasbohrer, A., & Pinior, B. (2017). 
A systematic worldwide review of the direct monetary losses in cattle due to bovine 




Ridpath, J. F. (2010). Bovine Viral Diarrhea Virus: Global Status. Veterinary Clinics of 
North America: Food Animal Practice, 26(1), 105-121. 
https://doi.org/10.1016/j.cvfa.2009.10.007 
Ridpath, J. F. (2013). Immunology of BVDV vaccines. Biologicals, 41(1), 14-19. 
https://doi.org/10.1016/j.biologicals.2012.07.003 
Ridpath, J. F., & Bolin, S. R. (1998). Differentiation of types 1a, 1b and 2 bovine viral diarrhoea 
virus (BVDV) by PCR. Molecular and Cellular Probes, 12(2), 101-106. 
https://doi.org/10.1006/mcpr.1998.0158 
Ridpath, J. F., Lovell, G., Neill, J. D., Hairgrove, T. B., Velayudhan, B., & Mock, R. (2011). 
Change in Predominance of Bovine Viral Diarrhea Virus Subgenotypes among 
Samples Submitted to a Diagnostic Laboratory over a 20-Year Time Span. Journal of 
Veterinary Diagnostic Investigation, 23(2), 185-193. 10.1177/104063871102300201 
Rikula, U., Nuotio, L., Aaltonen, T., & Ruoho, O. (2005). Bovine viral diarrhoea virus control 
in Finland 1998–2004. Preventive Veterinary Medicine, 72(1-2), 139-142. 
Roberts, P. C., Etchison, J. R., & Bond, C. W. (1988). A rapid, quantitative assay for titration 
of bovine virus diarrhoea-mucosal disease virus. Veterinary Microbiology, 18(3), 209-
217. https://doi.org/10.1016/0378-1135(88)90088-0 
Robesova, B., Kovarcik, K., & Vilcek, S. (2009). Genotyping of bovine viral diarrhoea virus 
isolates from the Czech Republic. Veterinarni Medicina, 54(9), 393-398. 
10.17221/3053-vetmed 
Rossi, C. R., & Kiesel, G. K. (1971). Microtiter Tests for Detecting Antibody in Bovine Serum 
to Parainfluenza 3 Virus, Infectious Bovine Rhinotracheitis Virus, and Bovine Virus 
Diarrhea Virus. Applied Microbiology, 22(1), 32-36. 
Ruckerbauer, G. M., Girard, A., Bannister, G., & Boulanger, P. (1971). Studies on bovine virus 
diarrhea: serum neutralization, complement-fixation and immunofluorescence. 
Canadian Journal of Comparative Medicine, 35(3), 230. 
Saliki, J. T., & Dubovi, E. J. (2004a). Laboratory diagnosis of bovine viral diarrhea virus 
infections. The Veterinary clinics of North America. Food animal practice, 20(1), 69-
83. 10.1016/j.cvfa.2003.11.005 
Saliki, J. T., & Dubovi, E. J. (2004b). Laboratory diagnosis of bovine viral diarrhea virus 
infections. Veterinary Clinics of North America: Food Animal Practice, 20(1), 69-83. 
https://doi.org/10.1016/j.cvfa.2003.11.005 
Saliki, J. T., Fulton, R. W., Hull, S. R., & Dubovi, E. J. (1997). Microtiter virus isolation and 
enzyme immunoassays for detection of bovine viral diarrhea virus in cattle serum. 
Journal of Clinical Microbiology, 35(4), 803-807. 
Salisbury, R. M., Hartley, W. J., McIntosh, I. G., Hansen, N. F., Te Punga, W. A., & Jamieson, 
S. (1961). A mucosal disease-like syndrome of cattle in New Zealand. Bulletin de 
l'Office International des Epizooties, 56, 62-78; 79-98 pp. 
Sandvik, T. (1999). Laboratory diagnostic investigations for bovine viral diarrhoea virus 




Sandvik, T. (2005a). Selection and use of laboratory diagnostic assays in BVD control 
programmes. Preventive Veterinary Medicine, 72(1-2), 3-16. 
Sandvik, T. (2005b). Selection and use of laboratory diagnostic assays in BVD control 
programmes. Preventive Veterinary Medicine, 72(1), 3-16. 
https://doi.org/10.1016/j.prevetmed.2005.08.015 
Sandvik, T., & Krogsrud, J. (1995). Evaluation of an Antigen-Capture ELISA for Detection of 
Bovine Viral Diarrhea Virus in Cattle Blood Samples. Journal of Veterinary Diagnostic 
Investigation, 7(1), 65-71. 10.1177/104063879500700110 
Santman-Berends, I. M. G. A., Mars, M. H., van Duijn, L., & van Schaik, G. (2015). Evaluation 
of the epidemiological and economic consequences of control scenarios for bovine viral 
diarrhea virus in dairy herds. Journal of Dairy Science, 98(11), 7699-7716. 
http://dx.doi.org/10.3168/jds.2014-9255 
Sayers, R. G., Sayers, G. P., Graham, D. A., & Arkins, S. (2015). Impact of three inactivated 
bovine viral diarrhoea virus vaccines on bulk milk p80 (NS3) ELISA test results in 
dairy herds. The Veterinary Journal, 205(1), 56-61. 
Scharnböck, B., Roch, F.-F., Richter, V., Funke, C., Firth, C. L., Obritzhauser, W., . . . Pinior, 
B. (2018). A meta-analysis of bovine viral diarrhoea virus (BVDV) prevalences in the 
global cattle population. Scientific Reports, 8(1), 14420. 10.1038/s41598-018-32831-2 
Scharnbock, B., Roch, F. F., Richter, V., Funke, C., Firth, C. L., Obritzhauser, W., . . . Pinior, 
B. (2018). A meta-analysis of bovine viral diarrhoea virus (BVDV) prevalences in the 
global cattle population. Scientific Reports, 8, 15. 10.1038/s41598-018-32831-2 
Schrijver, R. S., & Kramps, J. A. (1998). Critical factors affecting the diagnostic reliability of 
enzyme-linked immunosorbent assay formats. Rev Sci Tech, 17(2), 550-561. 
10.20506/rst.17.2.1117 
Seki, Y., Seimiya, Y. M., Yaegashi, G., & Sato, C. (2006). Identification of Herds with Cattle 
Persistently Infected with Bovine Viral Diarrhea Virus by Virological Evaluation of 
Three Calves. Journal of Veterinary Medical Science, 68(3), 255-258. 
10.1292/jvms.68.255 
Shannon, A. D., Richards, S. G., Kirkland, P. D., & Moyle, A. (1991). An antigen-capture 
ELISA detects pestivirus antigens in blood and tissues of immunotolerant carrier cattle. 
Journal of Virological Methods, 34(1), 1-12. https://doi.org/10.1016/0166-
0934(91)90116-H 
Simmonds, P., Becher, P., Bukh, J., Gould, E. A., Meyers, G., Monath, T., . . . Stapleton, J. T. 
(2017). ICTV virus taxonomy profile: Flaviviridae. Journal of General Virology, 98(1), 
2-3. 10.1099/jgv.0.000672 
Simmonds, P., Becher, P., Bukh, J., Gould, E. A., Meyers, G., Monath, T., . . . Consortium, I. 
R. (2017). ICTV Virus Taxonomy Profile: Flaviviridae. Journal of General Virology, 
98(1), 2-3. 10.1099/jgv.0.000672 
Smith, D. B., Becher, P., Bukh, J., Gould, E. A., Meyers, G., Monath, T., . . . Simmonds, P. 
(2016). Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus 




Smith, G. H., Collins, J. K., Carman, J., & Minocha, H. C. (1988). Detection of cytopathic and 
noncytopathic bovine viral diarrhea virus in cell culture with an immunoperoxidase test. 
Journal of Virological Methods, 19(3), 319-324. https://doi.org/10.1016/0166-
0934(88)90026-2 
Smith, R. L., Sanderson, M. W., Walz, P. H., & Givens, M. D. (2008). Sensitivity of 
polymerase chain reaction for detection of bovine viral diarrhea virus in pooled serum 
samples and use of pooled polymerase chain reaction to determine prevalence of bovine 
viral diarrhea virus in auction market cattle. Journal of Veterinary Diagnostic 
Investigation, 20(1), 75-78. 10.1177/104063870802000115 
Ståhl, K., & Alenius, S. (2012). BVDV control and eradication in Europe - an update. The 
Japanese journal of veterinary research, 60 Suppl, S31-39. 
Ståhl, K., Kampa, J., Baule, C., Isaksson, M., Moreno-López, J., Belák, S., . . . Lindberg, A. 
(2005a). Molecular epidemiology of bovine viral diarrhoea during the final phase of the 
Swedish BVD-eradication programme. Preventive Veterinary Medicine, 72(1), 103-
108. https://doi.org/10.1016/j.prevetmed.2005.01.021 
Ståhl, K., Kampa, J., Baule, C., Isaksson, M., Moreno-López, J., Belák, S., . . . Lindberg, A. 
(2005b). Molecular epidemiology of bovine viral diarrhoea during the final phase of 
the Swedish BVD-eradication programme. Preventive Veterinary Medicine, 72(1–2), 
103-108. http://dx.doi.org/10.1016/j.prevetmed.2005.01.021 
Stalder, H., Bachofen, C., Schweizer, M., Zanoni, R., Sauerländer, D., & Peterhans, E. (2018). 
Traces of history conserved over 600 years in the geographic distribution of genetic 
variants of an RNA virus: Bovine viral diarrhea virus in Switzerland. PLoS ONE, 
13(12), 1-17. 10.1371/journal.pone.0207604 
Stalder, H., Hug, C., Zanoni, R., Vogt, H.-R., Peterhans, E., Schweizer, M., & Bachofen, C. 
(2016). A nationwide database linking information on the hosts with sequence data of 
their virus strains: A useful tool for the eradication of bovine viral diarrhea (BVD) in 
Switzerland. Virus Research, 218, 49-56. 
https://doi.org/10.1016/j.virusres.2015.09.012 
Swofford, D. L. (2002). PAUP*: Phylogenetic analysis using parsimony (and other methods) 
4.0 Beta, Version 10. Sunderland, MA, USA: Sinauer.  
Tautz, N., Tews, B. A., & Meyers, G. (2015). Chapter Two - The Molecular Biology of 
Pestiviruses. In M. Kielian, K. Maramorosch, & T. C. Mettenleiter (Eds.), Advances in 
Virus Research (Vol. 93, pp. 47-160): Academic Press. 
https://doi.org/10.1016/bs.aivir.2015.03.002 
Thobokwe, G., Heuer, C., & Hayes, D. (2004). Validation of a bulk tank milk antibody ELISA 
to detect dairy herds likely infected with bovine viral diarrhoea virus in New Zealand. 
New Zealand Veterinary Journal, 52(6), 394-400. 
Thobokwe, G., Heuer, C., & Hayes, D. P. (2004). Validation of a bulk tank milk antibody 
ELISA to detect dairy herds likely infected with bovine viral diarrhoea virus in New 
Zealand. New Zealand Veterinary Journal, 52(6), 394-400. 
10.1080/00480169.2004.36457 
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994). CLUSTAL W: Improving the 
sensitivity of progressive multiple sequence alignment through sequence weighting, 
76 
 
position-specific gap penalties and weight matrix choice. Nucleic Acids Research(22), 
4673. 10.1093/nar/22.22.4673 
Thomson, R., & Savan, M. (1963). Studies on virus diarrhea and mucosal disease of cattle. 
Canadian Journal of Comparative Medicine and Veterinary Science, 27(9), 207. 
Thür, B., Zlinszky, K., & Ehrensperger, F. (1996). Immunohistochemical detection of bovine 
viral diarrhea virus in skin biopsies: a reliable and fast diagnostic tool. Journal of 
Veterinary Medicine, Series B, 43(1‐10), 163-166. 
Toplak, I., Barlic-Maganja, D., Hostnik, P., & Grom, J. (2002). Genetic heterogeneity of bovine 
viral diarrhoea virus (BVDV) strains isolated in Slovenia. Slovenian Veterinary 
Research, 39(2), 115-124. 
Toplak, I., Sandvik, T., Barlic-Maganja, D., Grom, J., & Paton, D. J. (2005). Genetic typing of 
bovine viral diarrhoea virus: most Slovenian isolates are of genotypes 1d and 1f (vol 
99, pg 175, 2004). Veterinary Microbiology, 105(2), 159-159. 
10.1016/j.vetmic.2004.10.003 
Valle, P., Martin, S., Tremblay, R., & Bateman, K. (1999). Factors associated with being a 
bovine-virus diarrhoea (BVD) seropositive dairy herd in the Møre and Romsdal County 
of Norway. Preventive Veterinary Medicine, 40(3-4), 165-177. 
van Duijn, L., Veldhuis, A. M. B., Mars, M. H., de Roo, B., & Lam, T. J. G. M. (2019). Efficacy 
of a voluntary BVDV control programme: Experiences from the Netherlands. The 
Veterinary Journal, 245, 55-60. https://doi.org/10.1016/j.tvjl.2018.12.016 
Van Zaane, D. (1984). Use of Monoclonal Antibodies in Virus Diagnosis. In Recent Advances 
in Virus Diagnosis (pp. 145-156): Springer. 
Vilček, Š., Björklund, H. V., Belák, S., Horner, G. W., & Meers, J. (1998). Genetic typing of 
pestiviruses from New Zealand. New Zealand Veterinary Journal, 46(1), 35-37. 
10.1080/00480169.1998.36048 
Vilcek, S., Durkovic, B., Kolesarova, M., & Paton, D. J. (2005). Genetic diversity of BVDV: 
Consequences for classification and molecular epidemiology. Preventive Veterinary 
Medicine, 72(1), 31-35. 10.1016/j.prevetmed.2005.08.004 
Vilček, Š., Paton, D. J., Durkovic, B., Strojny, L., Ibata, G., Moussa, A., . . . Palfi, V. (2001). 
Bovine viral diarrhoea virus genotype 1 can be separated into at least eleven genetic 
groups. Archives of Virology, 146(1), 99. 10.1007/s007050170194 
Voges, H. (2008). A national survey of BVD exposure amongst New Zealand dairy herds based 
on bulk milk testing by antibody ELISA (Vol. Proceedings of the Society of Dairy Cattle 
Veterinarians of the NZVA Annual Conference): VetLearn Foundation. 
Volker, M., Hans, H., & Ann, L. (2005). BVD control in Europe: current status and 
perspectives. Animal Health Research Reviews(1), 63. 
Walz, P. H., Grooms, D. L., Passler, T., Ridpath, J. F., Tremblay, R., Step, D. L., . . . Givens, 
M. D. (2010). Control of Bovine Viral Diarrhea Virus in Ruminants. Journal of 
Veterinary Internal Medicine, 24(3), 476-486. 10.1111/j.1939-1676.2010.0502.x 
Wang, L., Wu, X., Wang, C., Song, C., Bao, J., & Du, J. (2020). Origin and transmission of 
bovine viral diarrhea virus type 1 in China revealed by phylodynamic analysis. 
Research in Veterinary Science, 128, 162-169. 10.1016/j.rvsc.2019.11.015 
77 
 
Weir, A. M. (2016). Epidemiology of BVD in New Zealand dairy herds : a thesis presented in 
partial fulfilment of the requirements for the degree of Doctor of Philosophy in 
Veterinary Epidemiology at Massey University, Manawatu, New Zealand. (Doctor of 
Philosophy (PhD) Doctoral), Massey University, Retrieved from 
http://hdl.handle.net/10179/11458 
Wilhelmsen, C. L., Bolin, S. R., Ridpath, J. F., Cheville, N. F., & Kluge, J. P. (1990). 
Experimental Primary Postnatal Bovine Viral Diarrhea Viral Infections in Six-month-
old Calves. Veterinary Pathology, 27(4), 235-243. 10.1177/030098589002700404 
Wolfmeyer, A., Wolf, G., Beer, M., Strube, W., Hehnen, H.-R., Schmeer, N., & Kaaden, O.-
R. (1997). Genomic (5′ UTR) and serological differences among German BVDV field 
isolates. Archives of Virology, 142(10), 2049-2057. 
Workman, A. M., Heaton, M. P., Harhay, G. P., Smith, T. P. L., Grotelueschen, D. M., 
Sjeklocha, D., . . . Chitko-McKown, C. G. (2016). Resolving Bovine viral diarrhea virus 
subtypes from persistently infected U.S. beef calves with complete genome sequence. 
Journal of Veterinary Diagnostic Investigation, 28(5), 519-528. 
10.1177/1040638716654943 
Xia, H., Liu, L., Wahlberg, N., Baule, C., & Belák, S. (2007). Molecular phylogenetic analysis 
of bovine viral diarrhoea virus: a Bayesian approach. Virus Research, 130(1-2), 53-62. 
Yesilbag, K., Alpay, G., & Becher, P. (2017). Variability and Global Distribution of 
Subgenotypes of Bovine Viral Diarrhea Virus. Viruses-Basel, 9(6), 19. 
10.3390/v9060128 
Zhang, S., Tan, B., Ding, Y., Wang, F., Guo, L., Wen, Y., . . . Wu, H. (2014). Complete genome 
sequence and pathogenesis of bovine viral diarrhea virus JL-1 isolate from cattle in 
China. Virology Journal, 11(1), 67. 10.1186/1743-422X-11-67 
Zimmer, G. M., Van Maanen, C., De Goey, I., Brinkhof, J., & Wentink, G. H. (2004). The 
effect of maternal antibodies on the detection of bovine virus diarrhoea virus in 




Appendix 1: Purification of viral RNA (spin protocol) 
 
The protocol is for purification of viral RNA from 140 µl serum. Larger volumes up to 560 µl 
can be processed by increasing the initial volumes proportionally and loading the QIAamp 
Mini spin column multiple times, as described below in the protocol. 
1. 650 µl of prepared Buffer AVL containing carrier RNA was pipetted into a 1.5 ml 
microcentrifuge tube. 
2. 140 µl of plasma was added to the Buffer AVL-carrier RNA into a microcentrifuge tube 
and was mixed for 15 seconds by pulse-vortexing.  
3. The mixture was incubated for 10 minutes and briefly centrifuged the tube to remove 
drops from the inside of the lid. 
4. 560 µl of ethanol (96-100%) was added to the sample and mixed by pulse-vortexing 
for 15 seconds. 
5. 630 µl of the lysate was added into the QIAamp Mini column without touching the 
Mini column membrane with the pipette tip and was centrifuged at 6000 x g for 1 
minute and placed the QIAamp mini column into a clean 2 ml collection tube after 
discarding the tube containing filtrate. 
6. The remaining solution of step 4 was added to the mini column and centrifuged for 
6000 x g for a one minute and the filtrate was removed, and the mini column was placed 
into a 2 ml collection tube. 
7.  500 µl of Buffer AW 1was added to the Mini column and centrifuged at 6000 x g for 
one minute and the filtrate was discarded, and the mini column was placed into a 2 ml 
collection tube provided. 
8. 500 µl of Buffer AW 2 was added to the Mini column and centrifuged for 20000 x g 
for three minutes and the Mini column was placed into a new 1.5 ml centrifuge tube 
(not provided) after discarding the filtrate. 
9. 60 µl of Buffer AVE was added to the Mini column placed in 1.5 ml centrifuge tube 
and incubated in room temperature for one minute. 
6–II 
 
10. The tube was centrifuged at 6000 x g for one minute and the Mini column was discarded 
and the filtrate (RNA) was stored in -810C until use for the PCR.        




Appendix 2: RT-PCR for BVD-5’UTR using primers P1/PEST 
 
Nucleic acid extraction Kit  
RNA Qiagen QIAamp Viral RNA extraction kit. 
 
Primers Name Sequence (5’-3’) Size Target 
Forward PI-U 5’-AGAGGCTAGCCATGCCCTTAGT-
3’ 
300 bp 5’UTR 
Reverse PEST 5’-TCAACTCCATGTGCCATGTAC-3’ 
 
PCR kit:  Invitrogen Superscript III RT/Platinum Taq kit  
Reagent mix RT-PCR Round Volume (50μL) 
Sterile distilled water 19.0 
2 X reaction buffer 25 
10 µM P1 Primer 0.2 uµ 
10 µM PEST Primer 0.2 uµ 
RT/Taq enzyme 0.2 uµ 
RNA 1 µg 
 
PCR Controls Description 
Positive BVD viral isolates in -800C freezer 
Negative Nuclease free water 
 
PCR Program for 5’UTR   
Cycling parameters: RT-PCR  Temp (oC) Time No. cycles 
Hold 42 15 min 1 
Hold  99 5 min 1 
Denature 94 45 sec  
40 Anneal 60 1 min 
6–IV 
 







Electrophoresis Description Size of amplicons(bp) 
Agarose gel  1.5%  300 bp 
MW marker 100 bp 
 
References: Grom, J. and Barlic-Maganja D. (1999) Bovine viral diarrhoea (BVD) infections-control and eradication 





Appendix 3: RT-PCR for BVD-NPro using primers B31/B32 
 
Nucleic acid extraction Kit  
RNA Qiagen QIAamp Viral RNA extraction kit. 
 
Primers Name Sequence (5’-3’) Size Target 





Reverse PEST 5’- TGCTACTAAAAATCTCTGCTGT -3’ 
 
PCR kit:  Invitrogen Superscript III RT/Platinum Taq kit  
Reagent mix RT-PCR Round Volume (50μL) 
Sterile distilled water 19.0 
2 X reaction buffer 25 
10 µM P1 Primer 0.2 uµ 
10 µM PEST Primer 0.2 uµ 
RT/Taq enzyme 0.2 uµ 
RNA 1 µg 
 
PCR Controls Description 
Positive BVD viral isolates in -800C freezer 
Negative Nuclease free water 
 
PCR Program for 5’UTR   
Cycling parameters: RT-PCR  Temp (oC) Time No. cycles 
Hold 45 30 min 1 
Hold  94 5 min 1 
Denature 94 45 sec  
40 Anneal 60 1 min 
6–VI 
 







Electrophoresis Description Size of amplicons(bp) 
Agarose gel  1.5%  441 bp 
MW marker 100 bp 
 
References: Grom, J. and Barlic-Maganja D. (1999) Bovine viral diarrhoea (BVD) infections-control and eradication 





Appendix 4: Gel electrophoresis procedure 
 
1. 1.5 %  ultra-pure agarose gel (Invitrogen, Waltham, MA, USA)was used for the gel 
preparation. 0.6 g of Agarose was used for 40 ml of gel preparation. 
2. 10 x TBE buffer was used to make agarose gel (0.6 g Agarose with 40 ml of x TBE) 
3. The mixer was put in a microwave to dissolve properly and placed the mixture in a 
water bath to make it slightly cold. 
4. 0. 2 µl of RedSafe (iNtRON Biotechnology, Kirkland, WA, USA) was added as the 
staining solution. 
5. The gel combs were placed in the gel plate and the solution was poured into the plates 
and left for about one hour to set the gel properly. 
6. 1 x TBE was poured into the electrophoresis tank and the gel was placed in the tank 
after removing the comb.  
7. The gel loadings were prepared and loaded to the gel as below.  
a. Ladder was prepared (3 µl of loading dye + 5 µl of distilled water + 5 µl of 
molecular marker) and 10 µl of the mix was added to the first well.  
b. Samples were prepared (3 µl of loading dye + 10 µl of sample) and 10 µl of the 
mixer was added to the wells one by one and the last two wells were loaded 
with negative control and positive control respectively. 
8. The gel was run in 100 V for an hour and the gel was inspected under a UV light, using 
a transilluminator for bands that matched the expected sizes of the genes of interest. 










Appendix 5: Protocol for purification of PCR products  
 
PureLinkR PCR Purification kit was used for cleaning PCR products  
 
1. 200 ml of binding buffer was added to B2 bottle (supplied with the kit), of it 160 µl of 
B2 was added to 40 µl of PCR products. 
2. All the mix was put into the PureLinkR Spin column in the collecting tube and 
centrifuged at 10,000 x g for one minute and the flow-through was discarded. 
3. The column was re-inserted into the collection tube and 650 µl of wash buffer (W1) 
was added and centrifuged for 10000 x g for one minute and  
4. The flow-through was discarded and the column was placed in the same centrifuge tube 
and centrifuged at 20000 x g for three minutes. 
5.  The column was placed into a 1.7 µl elution tube that comes with the kit and 50 µl of 
elution buffer was added to the centre of the column. 
6. The elution tube was incubated in room temperature for one minute and was centrifuged 
at 20000 x g for two minutes. 
7. The sip column was removed and the purified PCR products in the elution tube was 
stored at -200C until send for sequencing.  
